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EFFECT OF ETHANOL ON GLYCEROLIPIDS IN RAT LIVER
CHAPTER I
REVIEW OF THE LITERATURE
Glycerolipid Metabolism
Digestion and Absorption 
Pancreatic lipase attacks the ester linkage of fatty acids on 
the a- and a'-positions of glycerides. This intestinal enzyme is specific 
for long-chain fatty acids and catalyzes formation of a,p-diglycerides 
and p-monoglycerides. Conplete hydrolysis of glycerides probably occurs 
only after acyl migration of p-monoglycerides to form a-monoglycerides 
(1-3). Bile salts activate this lipase and act as an anionic detergent 
in émulsification of lipids to form micellar solutions wdiich contain free 
fatty acids (FFA), monoglycerides and small amounts of diglycerides and 
triglycerides. At least 25^ of ingested glyceride undergoes complete hy­
drolysis to glycerol and FFA. The remaining glyceride is absorbed pri­
marily as monoglyceride, with a very small amount of diglyceride and tri­
glyceride.
Absorption of glycerides, glycerol and FFA begins in the distal 
duodenum and is completed within the first 100 cm of the jejunum. Ab­
sorption across the intestinal mucosa involves a passive process and is
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therefore concentration but not energy dependent (4-6). Further hydroly­
sis of monoglyceride is catalyzed by monoglyceride lipase in the luminal 
cells of the intestine (7). Triglyceride re-synthesis via the a-glycero- 
phosphate pathway (8, 9) and by acylation of monoglycerides and digly­
cerides (10-13) has been observed in intestinal mucosal cells.
Dietary glycerides containing or shorter-chain fatty acids 
are handled in the intestine somevdiat differently than glycerides con­
taining longer-chain fatty acids. Intraluminal hydrolysis of glycerides 
containing or shorter-chain fatty acids is less extensive and re- 
esterification in the mucosal cell is much slower. These fatty acids 
are transported in the portal circulation to the liver vriiere a large pro­
portion is oxidized to carbon dioxide (14). 0^2 or longer-chain fatty
acids are re-esterified within the cytoplasmic matrix (15-16).
Phospholipids in the intestinal lumen are hydrolyzed by pancre­
atic phospholipase Ag, an enzyme which is specific for fatty acids ester- 
ified at the ^-position of glycerol (17). Bloom (18) reported that from 
60 to 100% of radioactivity administered as phospholipid-fatty acid was 
absorbed, but only from 15 to 30% remained in the phospholipid fraction. 
Artom and Swanson (l9) concluded that a significant proportion of phos­
pholipid is absorbed intact in micelles. Intestinal mucosal cells con­
tain a lysophosphatide hydrolase which converts lysophosphatide to a- 
glycerophosphate (20). However, the majority of the lysophosphatide in 
these cells is re-acylated.
Transport and betake by Tissues 
Lipid transport. Glycerides, phospholipids and cholesterol are 
transported from the intestine as chylomicrons. Chylomicrons are small
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light-scattering particles, varying in size from 0»5 to 1.0 mp. A non­
polar triglyceride core constitutes 85 to 90^ of these particles and, 
according to one concept of structure advocated by investigators in this 
field, is surrounded by a monomolecular film of protein, phospholipid 
and cholesterol (21-22). Chylomicrons in intestinal mucosal cells are 
released into the extracellular space, then proceed via the central lym­
phatic lacteals and the thoracic duct into the systemic circulation (23).
Lipids are also transported in plasma as components of other 
lipoproteins. Lipoproteins may be separated by ultracentrifugation into 
three main fractions. The very-low-density lipoprotein fraction, which 
includes chylomicrons, undergoes flotation at a solvent density of 1.006 
g per ml and contains approximately 55^ triglyceride, 22^ phospholipid, 
13^ cholesterol and 10^ protein. The low-density or p-lipoprotein frac­
tion is isolated in the density range from 1.006 to 1.063 g per ml and 
contains 11% triglyceride, 22% phospholipid, 46% cholesterol and 21% pro­
tein. The high-density or a-lipoprotein fraction is isolated in the den­
sity range from 1.063 to 1.210 g per ml and contains 6% triglyceride, 26% 
phospholipid, 18% cholesterol and 50% protein. Immunochemical studies 
have demonstrated that the protein moiety of each of these fractions is 
generally heterogeneous. Plasma FFA are transported as a component of 
these lipoproteins, although the majority are bound to albumin (24).
Uptake of plasma ukriqlvceride. The liver appears to be the ma­
jor site of chylomicron uptake from the systemic circulation (25-27). 
Electron microscopic studies have demonstrated that the endothelium in 
liver is discontinuous or fenestrated (28). Thus, chylomicrons may pass 
through the endothelium and enter the sub-endothelial spaces of Disse to
4
come into direct contact with hepatic parenchymal and reticuloendothelial 
cells. Chylomicron triglycerides may be hydrolyzed by lipolytic enzymes 
in or near the outer membrane of these cells (29) or, alternatively, 
chylomicrons may enter the cells by pinocytosis and then undergo lipoly- 
sis (30-31). Borgstrom and Jordan (32) have reported that chylomicron- 
triglyceride in which both the glycerol and fatty acid moieties were la­
beled was taken up initially by the liver as intact triglyceride. After 
10 minutes, however, a rapid decrease in the ratio of glycerol to fatty 
acid radioactivity was observed, indicating that the triglyceride from 
chylomicrons was being hydrolyzed. Within 4 hours, the radioactivity in 
fatty acids was equally distributed between triglyceride and phospholipid, 
principally phosphatidylcholine. In fasted animals, almost all of the 
radioactivity administered as labeled chylomicrons was recovered in the 
liver and respiratory carbon dioxide. When a similar expëriment was per­
formed in fed animals, however, only one-third of the radioactivity was 
recovered within the liver, whereas one-third was found in the adipose 
tissue and the remainder in other organs. The initial disappearance of 
chylomicrons from the circulation follows a simple exponential function 
with a half-time in rats of from 4 to 14 minutes (32-36). Liver perfusion 
studies reported by Morris (37) showed that less than 5% of chylomicron 
fatty acid was oxidized to carbon dioxide and less than 1̂  was converted 
to glycogen and protein. The majority was released into the perfusate 
as glycerolipids transported as lipoproteins or albumin-bound FFA. The 
glycerolipid fraction contained approximately twice as much radioactivity 
as the FFA.
Evidence that liver contains monoglyceride lipase (38) and tri-
glyceride lipase (39-45) has been reported. Triglyceride lipase activity 
has been observed in liver cell membrane (29, 41) and in microsomes (44) 
and other subcellular fractions. This lipase may be distinct from lipo­
protein lipase, an enzyme which has been demonstrated in plasma after 
heparin administration and also in adipose tissue, lung, heart and sev­
eral other tissues (46, 47). Liver from some animal species but not 
others has been found to contain an enzyme with characteristics similar 
to those described for lipoprotein lipase. A recent report by Mayes and 
Felts suggests the possibility that an inactive form of this enzyme is 
present in liver (48).
Chylomicron uptake by extrahepatic tissue apparently differs 
from that described for liver. Electron microscopic studies of the cap­
illary endothelium in extrahepatic tissues have failed to demonstrate the 
fenestrations observed in the endothelium of liver (49). The continuous 
endothelium found in extrahepatic tissues acts as a barrier for passage 
of intact chylomicrons. Lipoprotein lipase is bound on or near the cap­
illary endothelium. Robinson (49) has speculated that this enzyme cata­
lyzes an intravascular lipolysis of chylomicrons in extrahepatic tissue 
and consequently is primarily responsible for providing hydrolytic prod­
ucts of chylomicron triglyceride for utilization by these tissues.
Uptake of plasma johospholipid. Phospholipase Â  (specific for 
the a-acyl ester) and phospholipase A2 (specific for the p-acyl ester) 
in liver hydrolyze phosphatidylcholine and phosphatidylethanolamine to 
form the corre^onding §- and a-lysophosphatides (50). Phospholipase Â  
is present mainly in the microsomal fraction and Ag in the mitochondrial 
fraction. Lysophospholipases found primarily in the soluble fraction of
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liver catalyze the hydrolysis of these lysophosphatides to form glycero- 
phosphorylcholine and glycerophosphorylethanolamine, respectively (51, 
52). Kates (53) has reported that liver also contains phospholipase C, 
which converts phosphatidylcholine to diglyceride and phosphorylcholine. 
Phospholipase D, which converts phosphatidylcholine to phosphatidic acid 
and choline, has not been found in mammalian tissue.
Fatty Acid Oxidation 
Oxidation of fatty acids occurs primarily in the mitochondria 
of liver, muscle and other tissues. The following series of reactions 
constitute the p-oxidation pathway by which two-carbon units are removed 
from the fatty acid;
thiokinase y
1. R-CH-5-CHo-COOH + CoA-SH + ATP 7" > R-iCH,-CH,-C-S-CoA + AMP + PP
0 a,p-acyl-CoA dehydrogenase 0
2. R—CH2—CH2—0—S—CoA "t FAD ) R—CH — CH—&—S—CoA
+ FADH2
0 enoyl-CoA hydrase 0
3. R—CH = CH—C—S—CoA H2O  ̂ ^  R—CHOH—CH<5-C-S—CoA
0 p-hydroxyacyl-CoA dehydrogenase
4. R-CHOH-CHp-C-S-CoA + NAD'̂  ; ' ~
0 0 
R-6-CH2-&-S-C0A + NADH + H
g g p-ketothiolase 0 ÇJ
5. R-C-CHg-C-S-CoA + CoA-SH (  > R-C-S-CoA + CH3-C-S-C0A
For palmitic acid, the complete sequence of reactions is outlined by the
following equation:
CH3(CH2)i4-C00H + ATP + 8 CoA-SH + 7 NAD"*" + 7 FAD + 7 H2O
8 CH3C-S-C0A + AMP + PP -i- 7 NADH + 7 H^ + 7 FADH2
Complete oxidation of unsaturated fatty acids follows the p-oxi- 
dation cycle for the two-carbon units on the carboxylic and terminal 
methyl ends of the compounds. Enoyl CoA hydrase oxidizes a double bond 
only when the unsaturation is in the a,p position. Hence an isomerase 
is frequently required to catalyze the following reaction:
IA A/^/^Z cis-p,a:trans-a,p / ' = \/ V  V y V enoyl-CoA isomerase \g-S-CoA
Most naturally occurring polyunsaturated fatty acids have an all-cis con­
figuration with double bonds separated by a methylene group. Hydration 
of an a,p double bond with cis configuration produces a D-p-hydroxyacyl- 
CoA. The latter substance must be converted to the L-stereoisomer by an 
epimerase before further oxidation by p-hydroxya cyl-CoA dehydrogenase, 
wÆiich is specific for the L-stereoisomer. Both these enzymes are pres­
ent in mitochondria of all organs studied and are non-specific in respect 
to fatty acid chain length.
Fatty Acid Biosynthesis 
De novo synthesis of fatty acids in parenchymal cells of the 
liver is catalyzed by a multi-enzyme complex found in the cytoplasm. 
Saturated fatty acids, principally palmitic acid, are formed by a series 
of reactions involving acetyl-CoA and malonyl-CoA as substrates and acyl
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carrier protein (ACP), fatty acyl transacylases and several other enzy­
matic activities. This sequence of reactions apparently includes the 
following:
COOH
9 acetyl-CoA carboxylase f Q
1. CH^-C-S-CoA + CO, + ATP ( > CH,-C-S-CoA + ADP + Pi
biotin +
COOH COOH
I 9 fatty acyl transacylase | 0
2. CHg-C-S-CoA + ACP-SH (   > CHg-C-S-ACP + CoA-SH
0 fatty acyl transacylase 0
3. CH3-C-S-C0A + ACP-SH (  > CH3-C-S-ACP + CoA-SH
COOH9 I s  s 94. CHg-C-S-ACP + CHg-C-S-ACP ^ CH^-C-CHg-C-S-ACP + COg + ACP-SH
9 9 . OH 95. CH^-C-CH^-C-S-ACP + NADPH + H ( > CH^-CH-CH^-C-S-ACP + NADP+
9? 0  . 0
6 # CHg-CH—CH2"C—S—ACP  ̂ — CHg^CH = CH—C—S—ACP H2O
0 0
7. CH3-CH = CH-Ô-S-ACP + NADPH + H"̂   ̂ ~ ^ CH3-CH2-CH2-C-S-ACP + NADP"*
Formation of palmitic acid involves repetition of this cycle 
seven times and may be expressed by the following over-all equation (54):
9
8 CHg-C-S-CoA + 7 CO2 + 14 NADPH + 14 H"*"----------- > CH3-(CH2)i4-C00H
+ 7 CO2 + 14 NADP"̂  + 7 H2O + CoA-SH
Biosynthesis of monounsaturated fatty acids requires a mixed 
function oxidase, NADP and oxygen and a stereospecific fatty acid is pro­
duced. Although linoleic and linolenic acid cannot be synthesized in 
mammalian tissue, these fatty acids may be converted into several other 
polyunsaturated fatty acids, including arachidonic acid, by chain elon­
gation and introduction of additional double bonds. Chain elongation of 
fatty acids appears to be accomplished primarily in mitochondria by re­
versal of the p-oxidation cycle. Several of the enzymes which partici­
pate in the p-oxidation pathway are apparently involved in this sequence 
of reactions in which two-carbon units are added to fatty acids.
Ganguly (55), Numa et al. (56) and Martin and Vagelos (57) dem­
onstrated that carboxylation of acetyl-CoA to form malonyl-CoA was rate- 
limiting in fatty acid synthesis. Langdon (58), Siperstein (59, 60) and 
others (61, 62) have suggested that in some instances NADPH may also be 
rate-limiting.
Tricarboxylic acid cycle intermediates, particularly citrate, 
stimulate fatty acid synthesis. Vagelos and co-workers (63) have sug­
gested that citrate modifies the conformation of acetyl-CoA carboxylase. 
Citrate may also be converted to acetyl-CoA by the citrate cleavage en­




'2 enzyme 0 C-COOH




Inhibition of hepatic acetyl-CoA carboxylase and citrate synthetase, an 
enzyme involved in citrate formation, has been observed in animals fed 
a diet rich in fat or when CoA-derivatives of long-chain fatty acids were 
added to in vitro systems containing these enzymes (64, 65).
Glycerolipid Synthesis 
L-a-glycerophosphate may be formed in liver either from glycerol 
or dihydroxyacetone phosphate. Phosphorylation of the a-hydroxy group 
of glycerol is catalyzed by glycerokinase in the presence of ATP and mag­
nesium. a-Glycerophosphate may also be formed by hydrogenation of dihy­
droxyacetone phosphate. The latter pathway produces most of the a - g l y -  
cerophosphate formed in adipose tissue and intestinal mucosa, since gly­
cerokinase is virtually absent from these tissues. The major pathways 
involved in synthesis of triglyceride, phosphatidylcholine and phospha­
tidylethanolamine are shown in Figure 1. Alternate pathways for forming 
phosphatidylcholine from phosphatidylethanolamine and phosphatidyleth­
anolamine from phosphatidylserine are also presented.
Several radioactive precursors, primarily glycerol and fatty 
acids, have been utilized for studying glycerolipid metabolism. Gidez 
and Karnovsky (66) observed that the incorporation of radioactivity into 
triglycerides following administration of glycerol-Ĉ '̂  was considerably 
greater than in phospholipids. Maximal incorporation into all glycero­
lipids occurred during the first 30 minutes after isotope administration 
and was followed by an exponential decline in radioactivity vdiich was 
most rapid in triglycerides.
Although glycerolipids share a common pathway for the initial 
steps in their biosynthesis, the fatty acid composition of phospholipids
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Figure 1. Pathways of glycerolipid metabolism
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differs from that of triglycerides. In addition, the fatty acid compo­
sition of each lipid species may vary among different tissues. Goldman 
and Vagelos (67) demonstrated that the rate at viiiich diglycerides were 
acylated was dependent upon the fatty acid composition of the diglyceride 
as well as the fatty acyl-CoA derivative utilized. Several investigators 
(68-70) have observed that the rate at which Ĉ '̂ -methyl groups were trans­
ferred to phosphatidylethanolamine varied with the fatty acid composition 
of the phosphatidylethanolamine. Recent work reported by Lyman and co­
workers (71) indicates that phosphatidylethanolamines containing stearic 
and arachidonic acid are transmethylated preferentially to form the cor­
responding phosphatidylcholine.
Lands and associates (72-75) have described a group of fatty 
acyl CoA:lysophosphatide transferases in liver microsomes. These trans­
ferase activities catalyze the transfer of a series of fatty acids from 
their CoA-derivatives onto a- and p-lysophosphatidylcholine, lysophospha- 
tidylethanolamine and lysophosphatidic acid. Lands has proposed that 
the fatty acid composition of glycerolipids is determined primarily by 
the specificity of this group of transferases.
Triglyceride Metabolism in Adipose Tissue
Triglyceride turnover in adipose tissue is slow when body weight 
is maintained (76, 77). Studies in human subjects have demonstrated that 
adipose tissue triglyceride has a half-time greater than one year (78). •
Some selectivity in the type of fatty acid mobilized has been described 
(79-82) but in general the amount of each fatty acid released from the 
tissue parallels the concentration of that fatty acid in the tissue (78, 
83).
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Hydrolysis of adipose tissue triglycerides is catalyzed prima­
rily by a mitochondrial lipase which is activated by several hormones 
(hence the designation "hormone-sensitive lipase"). Norepinephrine, 
which may be released when sympathetic nerves are stimulated, activates 
this adipose tissue lipase but has little effect on hepatic and muscle 
phosphorylase. Administration of this catecholamine, therefore, pro­
duces a greater increase in plasma FFA than in blood glucose (84, 85). 
Epinephrine, derived from the adrenal medulla, activates hormone-sensi­
tive lipase of adipose tissue and also hepatic and muscle phosphorylase. 
Increased levels of plasma FFA as well as blood glucose are elicited by 
administration of this substance (86). Other hormones, including adrenal 
corticosteroids, aldosterone, thyroxine, corticotropin, thyroid stimulat­
ing hormone, glucagon and growth hormone, influence the lipolytic activ­
ity present in adipose tissue. Brodie and co-workers (86) have suggested 
that adrenal corticosteroids alter the electrolyte environment of this 
lipase and thereby increase its responsiveness to endogenous catechola­
mines. Adrenalectomized rats deprived of saline failed to respond to 
epinephrine. This response could be restored either by prior administra­
tion of saline or glucocorticoids. Evidence suggesting that thyroxine is 
involved in regulating the levels of adipose tissue lipase has been ob­
tained using thyroidectomized rats. Lipase activity in response to 
epinephrine stimulation was low in these animals and did not return to 
normal until several days after the administration of thyroxine (87). 
Corticotropin has some adipokinetic activity, although the dose required 
to demonstrate this response is large compared with physiological concen­
trations (87). Thus, corticotropin probably has little direct effect on
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lipolysis under normal conditions. Insulin in the presence of glucose 
accelerates fatty acid estérification in adipose tissue. Wood and co­
workers (88) have suggested that this effect is secondary to the presence 
of increased amounts of a-glycerophosphate formed by insulin-stimulated 
glycolysis. In a glucose-free media, insulin has been reported to in­
hibit lipase .activity (89).  ̂■
Activation of lipolytic activity in adipose tissue during star­
vation appears to be independent of epinephrine and norepinephrine, since 
neither adrenalectomy nor "chemical sympathectomy" induced by the admin­
istration of hexaméthonium prevents an increase in plasma FFA levels in 
fasted animals (90, 91). Inhibition of lipolysis produced by feeding 
glucose is probably due to an increase in a-glycerophosphate concentra­
tion (92), which accelerates the rate of re-esterification of FFA.
Pathogenesis of Fatty Liver 
Lipid accumulation in the liver has been observed following the 
administration of ethanol and various other substances, including carbon 
tetrachloride, ethionine, puromycin, white phosphorus, cesium, 4-amino- 
pyrazolopyrimidine, orotic acid, corticosteroids, corticotropin and fat 
mobilizing substance from the pituitary. Nutritional deficiencies in­
volving choline, lysine, threonine, tryptophan and prolonged fasting also 
produce an increased hepatic content of lipids. Changes in liver morph­
ology observed in each of these instances are similar, hence their cate­
gorization by the non-specific pathological teim "fatty liver”. Biochem­
ical mechanisms which may be responsible for accumulation of lipids, par­
ticularly triglyceride, in liver include those in which an increased syn­
thesis or a decreased removal of hepatic lipids is involved. Triglyceride
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and other lipids are produced by ̂  novo synthesis in liver. In addition, 
a significant amount of triglyceride can apparently be formed in liver by 
re-esterification of fatty acids mobilized from adipose tissue and trans­
ported to liver in blood. Excessive mobilization of fatty acids from 
adipose tissue is a significant factor in the fatty liver induced by cort­
icotropin, adrenocorticosteroids (93, 94), fat mobilizing substance (§5) 
and prolonged fasting (96). Carbon tetrachloride (97-102), white phos­
phorus (l03), ethionine (104-107), puromycin (l08) and orotic acid (109, 
110) impair hepatic protein synthesis. The fatty liver induced by the 
latter group of substances results from a decreased rate of serum lipo­
protein formation and is accompanied by low plasma lipid concentrations. 
Farber (ill, 112) observed low ATP levels in the liver of rats given 
ethionine and orotic acid and suggested that this deficiency results in 
disaggregation of polysomes. Adenine administration reverses the fatty 
liver produced by these substances (113, 114). Puromycin inhibits pep­
tide bond formation during protein synthesis on ribosomes (115).
The fatty liver found in choline deficiency is associated with . 
a decrease in serum lipids (116-118), an increase in hepatic fatty acid 
oxidation (ll9) and no change in the rate of hepatic triglyceride bio­
synthesis (120). Although hepatic phospholipid turnover is increased in 
this deficiency, the phospholipid content of liver (l2l) and the rate of 
conversion of phosphatidylethanolamine to phosphatidylcholine are low 
(116). Bernhard and associates (122) have postulated that choline defi­
ciency inçairs the lipoprotein secretory mechanism. Additional evidence 
favoring this conclusion was reported by Lombardi (l2l), who also sug­
gested that this defect is interrelated with an abnormal hepatic phospho-
16
lipid synthesis.
The association of liver disease and chronic alcoholism was 
first described by Addison in 1836 (l23). One of the more prominent ef­
fects of ethanol is the accumulation of triglyceride in the liver (124- 
127). Hepatic glyceride content is increased within 16 hours after a 
single large dose and levels up to ten-fold greater than control have 
been observed (128, 129). Less prominent changes are those associated 
with increases in hepatic .phospholipid, FFA and cholesterol, primarily 
the esterified fraction. The extent to which the latter group of lipids 
is increased is dependent on the amount and duration of ethanol consump­
tion (130, 131).
Ethanol administration produces increased serum levels of tri­
glyceride and, when larger doses are given chronically, of total choles­
terol and phospholipid (132-136). Plasma FFA levels are increased during 
chronic ethanol administration but are generally decreased following a 
single large dose (136-139).
The mechanism whereby ethanol alters hepatic and serum lipids 
is largely unknown. Lipid accumulations in the liver were initially 
thought to result from the nutritional deficiencies often found in chronic 
alcoholics (140, 141). Evidence that ethanol may exert a more direct in­
fluence on the pathogenesis of fatty liver is provided by recent studies 
in which lipid accumulation was observed in liver from human subjects and 
laboratory animals given moderate amounts of ethanol vriiile receiving a 
nutritionally-adequate diet (128, 129, 142, 143).
Metabolism of Ethanol 
Only 2 to 1C% of ethanol absorbed from the intestine is elimi-
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nated through the kidneys and lungs. Dehydrogenases present primarily 
in the soluble cytoplasmic portion of liver cells oxidize the remaining 
90 to 98% sequentially to acetaldehyde and acetate (l44). Oxidation of 
the NADH formed in the conversion of ethanol to acetate involves inter­
mediate carriers, i.e., p-hydroxybutyrate and a-glycerophosphate, to 
transport hydrogen across the mitochondrial membrane (l45). Increased 




The present study was undertaken to investigate the effect of 
chronic ethanol administration on rat liver glycerolipids. Specific ob­
jectives include investigating the effect of ethanol on (l) the concen­
trations of individual glycerolipids present in liver and plasma, (2) the 
fatty acid composition of triglyceride, phosphatidylcholine and phospha- 
tidylethanolamine in liver from rats fed diets containing corn oil or 
coconut oil as the sole source of fat, and (3) the fatty acyl-CoA:lyso- 
phosphatidylcholine and fatty acyl-CoA:lysophosphatidylethanolamine 





Male Holtzman rats, 4 to 6 months of age, weighing 350 to 450 g, 
were divided into two groups» Rats in each group were fed a liquid diet 
containing the ingredients listed in Table 1, in an amount sufficient to 
maintain body weight constant. These diets, which are similar to those 
described by Lieber and associates (l28), provided approximately 63^ of 
total calories as carbohydrate (corn dextrose, Clinton Corn Processing 
Co.), 18^ as fat [corn oil (Corn Products Co.) was the sole source of fat 
calories in all diets except those in which the substitution of coconut 
oil (Mangus Mabee and Reynard, Inc.) is indicated subsequently] and 19^ 
as protein (vitamin-free casein from Nutritional Biochemical Corp.),
Salts and minerals (Nutritional Biochemical Corp.), cod liver oil (E. R» 
Squibb and Sons) and additional vitamins and co-factors were added and 
the diet mixture was emulsified with powdered tragacanth gum (S. B. Penick 
Co.). Animals in the ethanol-treated group were fed a diet identical to 
that given the control group except that 95% ethanol (U. S. Industrial 
Chemical Co.) was substituted isocalorically for dextrose to provide ap­
proximately 40% of total calories, assuming a caloric equivalent of 7 







Dextrose (corn) 250.1 93.0
Ethanol 0.0 89.8
Corn oil or coconut oil 30.9 30.9
Vitamin-free casein i 75.6 75.6
Salts and minerals 
(Mixture USP XIV)
7.6 7.6
Vitamin and co-factor mixture^ 1.7 1.7
Cod liver oil 3.2 3.2
Powdered tragacanth gum 14.0 14.0
Water 697.7 697.7
Diet contained 1.58 calories per ml. Approximately 50 ml was 
required daily for maintaining body weight constant.
^The vitamin and co-factor mixture contained thiamine hydro­
chloride 0.25 g, riboflavin 0.50 g, pyridoxine hydrochloride 0.25 g, cal­
cium pantothenate 2.00 g, niacinamide hydrochloride 1.00 g, choline chlo­
ride 100.00 g, biotin 0.01 g, Vitamin 5^2 0.02 g, folic acid 0.10 g, in­
ositol 30.00 g, menadione 0.10 g and vitamin-free casein 258.48 g.
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tained on the formula diet for a period of 4 to 6 weeks and then sacri­
ficed by decapitation or exsanguination via the abdominal aorta. Body 
weight increased by 0.1% of initial value in the control group and de­
creased by 0.7% in the ethanol-treated group.
Isolation and Analysis of Hepatic 
and Serum Lipids
The liver from each rat was perfused immediately at the time of 
sacrifice with cold, isotonic saline. A portion of each liver was homo­
genized in a Waring blender with 10 ml of a solvent mixture containing 
chloroform and methanol (Fisher Scientific Co.) (2:1, v/v) per g of wet 
liver. Serum samples were extracted using 10 ml of the chloroform-meth- 
anol solvent mixture per ml of serum. The chloroform-methanol soluble 
portion was removed, the residue extracted three additional times with 
volumes of solvent mixture equal to that used in the initial extraction, 
and the extracts combined. The final residue was weighed and samples 
taken for nitrogen and deoxyribonucleic acid estimation. Nitrogen was 
determined by the Kjeldahl method (149) and deoxyribonucleic acid (DNA) 
according to the diphenylamine method of Burton (150).
The chloroform-methanol soluble extracts were analyzed for gly­
ceride by the method of Van Handel and Zilversmit (l5l), lipid phosphorus 
by the method of Gerlach and Deuticke (l52), and total and free choles­
terol by the method of Schoenheimer and Sperry (153).
Triglyceride from liver was isolated by thin-layer chromatog­
raphy on Silica Gel G (E. Merck Co.). Samples of the chloroform-methanol 
soluble extract were separated in a solvent mixture containing petroleum 
ether and diethyl ether (Fisher Scientific Co.) (95:5, v/v). The silica
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gel containing triglyceride was removed from the chromatography plate and 
extracted with the chloroform-methanol solvent mixture.
Pho^holipids in liver and serum were separated by two-dimen­
sional thin-layer chromatography on Silica Gel G. Samples of the chloro­
form-methanol soluble extract were separated sequentially in a solvent 
system containing chloroform, methanol and water (80:35:4, v/v) and a 
second solvent system containing chloroform, methanol, water and glacial 
acetic acid (Fisher Scientific Co.) (80:30:2:4, v/v). Good separation 
of phosphatidylcholine, phosphatidylethanolamine, lysophosphatidylcholine 
and sphingomyelin was obtained. The silica gel containing individual 
phospholipid fractions was removed from the chromatography plate and ana­
lyzed directly for phosphorus. Results obtained in quantitating indivi­
dual phospholipids were utilized only from those analyses in which total 
lipid phosphorus recoveries after separation were at least 95% of the 
lipid phosphorus value of the sample before separation.
Lipid Composition of Liver and Serum
Liver and serum from ten control and ten ethanol-treated rats 
were analyzed for triglyceride, total and free cholesterol and individ­
ual phospholipids, following the procedure outlined above.
Synthesis of Hepatic Triglyceride. Phosphatidylcholine 
and Phosphatidylethanolamihe
Ten microcuries of glycerol-U.L.-C^^ (New England Nuclear Corp.) 
was injected into the femoral vein of each of thirty control and thirty 
ethanol-treated rats under light ether anesthesia. The animals were 
then divided by a random number technique into six sub-groups and sub­
sequently sacrificed at 15, 30, 45, 70, 90, 120 and 240 minutes after
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isotope injection. The liver from each of these animals Was frozen imme­
diately in liquid nitrogen to minimize postmortem changes. Lipids were 
extracted and the triglyceride, phosphatidylcholine and phosphatidyletha- 
nolamine fractions'isolated by the. procedures outlined above. .Quantita­
tive chemical.analyses were performed on samples from each lipid fraction.
Radioactivity in each fraction was determined using a Nuclear- 
Chic ago Model 701 liquid scintillation counter. Samples of the trigly­
ceride fraction for liquid scintillation counting were dissolved in 10 ml 
of toluene (Fisher Scientific Co.) containing 2,5-diphenyloxazole (PPO) 
and 1,4-bis-[2-(5-phenyloxazolyl)]-benzene (POPOP) (Packard Instrument 
Co.). Samples of the phosphatidylcholine and phosphatidylethanolamine 
fractions, which have a limited solubility in toluene, were first dis­
solved in 1.0 ml of methanol and then an aliquot of the toluene solution 
containing PPO and POPOP was added. Quenching was estimated using both 
an internal standard and the channels ratio method (l54) and appropriate 
corrections were made to express radioactivity measurements as disinte­
grations per minute (dpm). Specific and total radioactivities of each 
lipid fraction were calculated and plotted against time.
Turnover of Hepatic Triqlvceride. Phosphatidvlcholine 
and Phosphatidylethanolamine
Thirty-five control and thirty-five ethanol-treated rats were 
each given 120 pCi of glycerol-2-H^ (New England Nuclear Co.) by intra- 
peritoneal injection. The animals were divided into six sub-groups using 
a random number technique and sacrificed at 48, 72, 96, 120 and 144 hours 
after isotope injection. Triglyceride, phosphatidylcholine and phospha­
tidylethanolamine fractions were isolated from each liver and quantita­
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ted by the chemical and radioactivity analyses described above. Total 
and specific radioactivities for each glycerolipid fraction were plotted 
against time and a regression analysis performed to determine the half- 
time values.
Fatty Acid Composition of Hepatic Triqlvceride, 
Phosphatidylcholine and Phosphatidyl- 
ethanolamine
Two groups of twenty control and twenty ethanol-treated rats 
were each equally divided into four sub-groups. One sub-group from each 
group was fed a diet for 46 days in which either corn oil or coconut oil 
was the sole source of fat. The fatty acid composition of corn oil is 
approximately 6(% linoleic acid and less than 2% myristic and shorter- 
chain length fatty acids, whereas that of coconut oil is approximately 
2̂  linoleic acid and 7 ^  myristic and shorter-chain length fatty acids 
(Table 2). The dietary fat for the remaining two sub-groups of each 
group was provided either by coconut oil for 42 days and then corn oil 
for the final 4 days, or by corn oil for 42 days and then coconut oil for 
the final 4 days. Triglyceride, phosphatidylcholine and phosphatidyl­
ethanolamine fractions were isolated from liver and a specimen of mesen­
teric adipose tissue obtained from each animal, following the procedures 
already described. Samples of each fraction were subjected to hydrolytic 
methanolysis using boron trifluoride in methanol (Applied Science Co.), 
according to the method of Morrison and Smith (155). The fatty acid 
methyl esters derived from this reaction were quantitated by gas-liquid 
chromatography using a Barber-Colman Model 5000 gas-liquid chromatograph, 
with a 6-foot, U-shaped glass column and a strontium-90 detector. The 
column was packed with Chromasorb W, 80 to 100 mesh, coated with 15% di-
25
TABLE 2
FATTY ACID COMPOSITION OF CORN OIL AND COCONUT OIL°
Fatty Acid Corn Oil Coconut Oil
"̂ 8:0 - 39.9
^lOiO - 22.1
^12:0 < 1 12.0





^ ^18:2 2.4 -
^Percent distribution of fatty acids analyzed by gas-liquid 
chromatography.
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ethylene glycol succinate (^plied Science Co.). Separations were per­
formed at a column temperature of 172* C, an injector temperature of 192 
0 and a detector temperature of 182* C, using argon (64 ml per minute at 
a pressure of 13.0 psi) as carrier gas. Individual peaks recorded dur­
ing the separation were identified by comparison with retention times of 
methyl esters prepared from reference fatty acids. The area under each 
fatty acid peak was estimated by triangulation and expressed as a percent 
of the total fatty acid present.
Assay of Fatty Acvl-Coenzvme A;Lvsophosphatide 
Transferase Actiyities in 
Liyer Microsomes
Isolation of Microsomal Fraction 
from Liyer
Liyer from fiye control and fiye ethanol-treated rats were per­
fused immediately with a cold, 0.25 M sucrose solution containing 1 mM 
ethylenediaminetetraacetic acid disodium salt (EDTA), pH 7.4. Each liyer 
was weighed and a portion obtained for lipid analyses. The remainder was 
homogenized in cold, sucrose-EDTA solution using a glass, Caputto-McCay 
hand homogenizer. The homogenate was centrifuged at 20,000 x g for 20 
minutes in a Seryall Model RC-2 centrifuge set at 4* C. The supernatant 
portion was decanted and centrifuged at 100,000 x g for 1 hour in a 
Beckman Spinco Model L-2 ultracentrifuge set at 4° C. The latter pre­
cipitate, containing the microsomal fraction, was suspended in a yolume 
of sucrose-EDTA solution equal to one-half the wet weight of liyer uti­
lized for homogenization and a sample remoyed for estimation of protein 
concentration by the Lowry method (156).
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Preparation of Substrates 
CoA-derivatives of palmitic, stearic, oleic, linoleic and arach- 
idonic acid (Sigma Chemical Co.) were prepared according to the method 
of Goldman and Vagelos (67). Gas-liquid chromatographic analysis of each 
fatty acid demonstrated a single peak with the appropriate retention time. 
Equal parts of fatty acid and ethyl chloroformate (Eastman Organic Chem­
ical Co.), dissolved in tetrahydrofuran (Eastman Organic Chemical Co.), 
were reacted at room temperature to form a mixed fatty acyl anhydride in 
a minimum yield of 95^ of theoretical. Four parts of the fatty acyl 
mixed anhydride, dissolved in tetrahydrofuran, and one part of an aqueous 
solution of the purified lithium salt of reduced Coenzyme A (Pabst Lab­
oratory) were reacted at 34* C, pH 7.5 to 8.0, under a nitrogen atmos­
phere. The fatty acyl-CoA derivative was precipitated with cold 10^ 
perchloric acid (Fisher Scientific Co.) and the adenine to fatty acid 
ratio determined. Adenine was estimated by measuring the absorbance 
peak at 260 mp in a Cary Model 14-PM recording spectrophotometer. Fatty 
acids were quantitated by gas-liquid chromatography, using palmitic or 
stearic acid as an internal standard. Ratios of adenine to fatty acid 
for the five fatty acyl-CoA derivatives were from 0.93 to 1.04. Yields 
of fatty acyl-CoA derivatives were from 8 to 15^ of theoretical.
The a-acyl derivatives of L-a-glycerophosphorylcholine and L- 
a-glycerophosphorylethanolamine, hereinafter designated as a-lysophospha- 
tidlycholine and a-lysophosphatidylethanolamine, respectively, were ob­
tained from Pierce Laboratories. Information provided by the vendor in­
dicates that these compounds were prepared by enzymatic déacylation of 
purified egg phosphatidylcholine and phosphatidylethanolamine. Thin-
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layer chromatography of the sample of a-lysophosphatidylcholine demon­
strated a single area which reacted with iodine and Dragendorff reagent 
for choline (157). Similar analysis of the sample of a-lysophosphatidyl- 
ethanolamine revealed a major area and a faint minor area, with a slight­
ly lower Rf value than the major area. Both reacted with ninhydrin and 
iodine.
The p-acyl derivatives of L-a-glycerophosphorylcholine and L- 
a-glycerophosphorylethanolamine, hereinafter designated as p-lysophos- 
phatidylcholine and p-lysophosphatidylethanolamine, respectively, were 
prepared from the corresponding plasmalogens. Phosphatidalcholine was 
isolated from beef heart and phosphatidalethanolamine from beef brain, 
^proximately 1.5 kg of beef heart and 1.0 kg of beef brain were each 
extracted with 20 volumes of a solvent mixture containing chloroform and 
methanol (2:1, v/v). The chloroform-methanol soluble portion was evapo­
rated to dryness in vacuo at room temperature using a rotating evaporator 
and the residue dissolved in diethyl ether. Two volumes of this ether 
solution was mixed with ten volumes of acetone (Fisher Scientific Co.) 
and one volume of a solution containing 50% magnesium chloride in ethanol. 
The precipitate vdiich formed was washed several times with a mixture con­
taining acetone and 50% magnesium chloride in ethanol (lO:l, v/v). This 
phospholipid-containing precipitate was dissolved in chloroform and sep­
arated using silicic acid column chromatography. Silicic acid 
(Mallinckrodt Chemical Co.), 100 to 200 mesh, was activated at 120* C 
for 3 hours. A slurry of activated silicic acid in chloroform was placed 
in a 2.5 x 45 cm glass column. The amount of the phospholipid fraction 
applied to each column was adjusted to provide approximately 1 mg of phos­
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phorus per g of silicic acid. Flow was regulated at 1.0 to 1.25 ml per 
minute and the eluate was collected using a Buchler Model 3C-4004 auto­
matic fraction collector. Sequential elution was performed in a 4* C 
cold room, using chloroform followed by mixtures containing 5, 10, 20 
and 3C5é methanol in chloroform. Samples of each eluate fraction were 
analyzed by thin-layer chromatography and those fractions which demon­
strated a single area with the appropriate mobility for phosphatidyl­
choline and phosphatidylethanolamine were combined individually. Neither 
silicic acid nor thin-layer chromatography separates phosphatidalcholine 
from phosphatidylcholine or phosphatidalethanolamine from phosphatidyl­
ethanolamine. Quantitation of plasmalogen performed by potentiometric 
titration using the method described by Norton (l58) indicated that phos­
phatidalcholine contained approximately 6(% of the phosphorus in the 
phosphatidylcholine fraction and phosphatidalethanolamine contained ap­
proximately 30^ of the phosphorus in the phosphatidylethanolamine frac­
tion. Phosphatidalcholine and phosphatidalethanolamine were converted 
to p-lysophosphatidylcholine and p-lysophosphatidylethanolamine, respec­
tively, just prior to use by treating the plasmalogen with iodine accord­
ing to the procedure described by Lands and Merkl (72). Further purifi­
cation of the p-lyso derivatives was not attempted since Lands and Merkl 
(72) reported that extensive acyl migration, resulting in a mixture of a- 
and p-lyso derivatives, had been obtained when the p-lyso derivatives 
were separated by silicic acid chromatography. These investigators 
demonstrated however that the addition of phosphatidylcholine did not af­
fect the rate at which lysophosphatidylcholine was acylated.
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Procedure for Assay of Transferase Activity 
Transferase activity was assayed by a modification of the pro­
cedure described by Lands and co-workers (75). Five milligrams of the 
a- or p-lyso derivative of phosphatidylcholine or phosphatidylethanol­
amine was dissolved in a small volume of chloroform and mixed with 10 ml 
of a 3^ aqueous solution of gum arabic. The chloroform was evaporated 
in vacuo at room temperature. The assay mixture contained, in a final 
volume of 1.0 ml, 30 mpmoles of the lysophosphatide suspended in 3^ gum 
arabic, 30 mjimoles of the fatty acyl-CoA derivative, 0.2 ml of microsomal 
fraction containing 0.10 to 0.25 mg of protein, 0.1 ml of a 0.01 M solu­
tion (pH 7.0) of the sodium salt of 5,5'-dithio-bis-(2-nitrobenzoic acid) 
(DTN) (Sigma Chemical Co.) and 70 pmoles of Tris buffer, pH 7.4. DTN 
reacts with reduced thiol groups to form a product which absorbs at 414 
mp. Transferase activity in the assay mixture was measured by monitor­
ing the appearance of reduced Coenzyme A, a product of the transferase- 
catalyzed acylation reaction. Optical density at 414 mp was recorded 
continuously during the first several minutes of reaction using a Beckman 
Model DU spectrophotometer equipped with a Sargent multiple sample re­
corder. A linear increase in optical density was observed during the 
initial period of reaction, as demonstrated by the representative example 
shown in Figure 2. The linear portion of each curve was evaluated to de­
termine maximal velocity (maximal change in optical density during a 
1-minute period). The maximal velocity values from duplicate assays 
were averaged and the latter values used in calculating rates. These re­
sults are presented as mpmoles of Coenzyme A released per minute per mg 













Figure 2. Time course of a representative assay of fatty acyl- 
Coenzyme A:lysophosphatide transferase activity in rat liver microsomes.
This assay mixture contained, in a final volume of 1.0 ml, 30 
mpinoles of p-lysophosphatidylcholine suspended in 3^ gum arabic, 30 
mpmoles of oleyl-CoA, 0.2 ml of microsomal fraction (containing 0.116 mg 
of protein) from the liver of a control, 0.1 ml of 0.01 M DTN solution 
and 70 pmoles of Tris buffer, pH 7.4.
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fatty acyl-CoA derivative was measured using an assay mixture from which 
the lysophosphatide was omitted. Transferase activity observed for each 
fatty acyl-CoA derivative was corrected for acyl-CoA hydrolase activity 
by subtracting the value obtained in the assay mixture containing no lyso­
phosphatide from that obtained in the complete assay mixture.
CHAPTER IV
RESULTS
Effect of Ethanol on Hepatic and 
Serum Glycerolipids
Chronic administration of ethanol to rats produced an increase 
in hepatic triglyceride, cholesterol and phospholipid (Table 3)o The 
most pronounced change was observed in the hepatic content of triglycer­
ide, which increased by 383^ of control (p < 0.001), and esterifled cho­
lesterol, which increased by 964% (p < 0.001). A significant increase 
was also observed in the total content of hepatic phospholipid (32% of 
control, p < 0.001), as well as in phosphatidylcholine (38%, p < O.OOl), 
phosphatidylethanolamine (26%, p < O.OOl) and sphingomyelin (79%, p < 
O.OOl). The magnitude of the increment in phospholipids, however, was 
much less than that observed in triglyceride and esterified cholesterol. 
Changes produced by ethanol in the concentration of individual hepatic 
lipid fractions, calculated relative to wet weight of liver, were similar 
qualitatively to those observed in the total content of these lipids in 
liver. The wet weight of liver from ethanol-treated rats increased by 
14% of control (p < 0.01) and the protein content by 66% (p < 0.01)
(Table 4). Hepatic DNA content was similar in control and ethanol-treated 
rats.
Increased serum concentrations of triglyceride (107% of control,
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TABLE 3
EFFECT OF ETHANOL ON HEPATIC LIPID COMPOSITION‘S
Total Content (mg) Percent of Total Concentration (mg/g wet wt)
Control Ethanol pb Control Ethanol Control Ethanol
Triglyceride 71.5+4.20 345.4+52.50 0.001 7. ̂ 0.55 30.7+4.44 0.001
Cholesterol
Total 17.6+0.98 53.3+ 4.96 0.001 1.7+0.15 4.0+0.65 0.01
Free 14.1+1.07 21.3+ 2.66 0.02 82.0 39.5 1.4+0.10 1.6+0.18 ns
Ester 3.0+0.46 32.0+ 5.91 0.001 18.0 60.5 0.3+0.05 2.4+0.47 0.001
Phospholipid
Total 191.4+4.47 252.4+ 5.33 0.001 16.7+1.03 21.0+2.30 ns
Phosphatidyl­
choline 100.1+2.30 138.3+ 3.66 0.001 52.3 54.8 8.7+0.54 11.7+0.50 0.001
Phosphatidyl­
ethanolamine 49.1+1.17 61.9+ 0.99 0.001 25.7 24.9 4.3+0.26 5.2+0.18 0.01
Sphingomyelin 8.9+0.65 15.9+ 0.95 0.001 3.0 4.0 0.8+0.09 1.4+0.15 0.01
^Values are presented as the mean, + standard error. Samples from 10 rats in each group were 
analyzed for triglyceride and phospholipids; samples from 7 rats in each group were analyzed for cho­
lesterol .
Statistical significance of difference between mean values obtained in ethanol-treated and 
control groups; ns indicates difference is not significant at 0.05 level.
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TABLE 4
EFFECT OF ETHANOL ON HEPATIC WEIGHT 
AND PROTEIN AND DNA CONTENT^
Control Ethanol p"
Liver Weight (g) 11,3+0,53 14,1+0,66 0,01
Protein (g) 1.4+0.12 2.3+0.22 0,01
DNA (mg) 16.9+1.41 17.^3.55 ns
Values are presented as the mean, + standard error. Liver
weights were obtained for all 10 rats in each group. Samples from 7 rats
in each group were analyzed for protein; samples from 5 rats in each 
group were analyzed for MJA.
^Statistical significance of difference between mean values ob­
tained in ethanol-treated and control groups ; ns indicates difference is
not significant at 0.05 level.
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p < O.Ol), cholesterol (11C%, p < O.OOl) and phospholipid (42̂ , p <
O.OOl) were found in the rats given ethanol (Table 5). The proportion 
of serum cholesterol present in the ester fraction was lower in the 
ethanol-treated rats than in the control group. The proportions of serum 
phospholipid present as phosphatidylcholine and phosphatidylethanolamine 
were increased in ethanol-treated rats, whereas the relative amount of 
sphingomyelin was unchanged and lysophosphatidylcholine was decreased.
Effect of Ethanol on Glvcerolipid Svnthesis 
The incorporation of radioactivity from glycerol-U.L.-C^^ into 
hepatic glycerolipids is presented in Figures 3 and 4. Specific radio­
activities of hepatic triglyceride (Fig. 3) were greater, usually by a 
substantial amount, than those of hepatic phosphatidylcholine and phos­
phatidylethanolamine (Fig. 4). Maximal incorporation into triglyceride 
occurred within 30 minutes after glycerol administration. During the 
first 2-hour period after isotope administration, the total radioactivity 
incorporated into hepatic triglyceride was 56% greater in ethanol-treated 
rats than controls (Table 6).
The total radioactivity incorporated into phosphatidylcholine 
in control and ethanol-treated rats increased rapidly and reached a peak 
at 30 minutes after isotope administration (Fig. 4). A second peak in 
these incorporation curves was observed at 90 minutes, y^proximately 35% 
more radioactivity was incorporated into phosphatidylcholine in the 
ethanol-treated rats than in controls during the first 2-hour period after 
isotope injection (Table 6).
The incorporation curves for hepatic phosphatidylethanolamine 
from control and ethanol-treated rats were relatively flat, although a
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TABLE 5
EFFECT OF ETHANOL ON SERUM LIPIDS
Concentration (mg/lOO ml) Percent of Total
Control Ethanol Control Ethanol
Triglyceride 24.1+2.07 49.9+ 7.21 0.01
Cholesterol
Total• 47.0+2.45 98.% 8.65 0.001
Free 9.5+1.29 41.4+ 6.40 0.01 20.4 43.6
Ester 37.5+2.87 57,1+11.84 ns 79.6 56.4
Phospholipid
Total 113.3+4,64 160,6+ 5.01 0.001
Phosphatidyl­
choline 57,4+2.35 94.4+ 2,94 0,001 50,7 58.8
Phosphatidyl­
ethanolamine 2,0+0.08 4.3+ 0.13 0.001 1.8 2.7
Sphingomyelin lO.C+0.41 13.7+ 0.43 0.001 8.8 8.5
Lysophospha­
tidyl choline 38.2+1.56 37.9+ 1.18 ns 33.7 23.6
^Values are presented as the mean, + standard error. Samples
from 18 rats in each group were analyzed for triglyceride and phospho­
lipids; samples from 5 rats in each group were analyzed for cholesterol.
^Statistical significance of difference between values obtained 
for ethanol-treated and control groups; ns indicates difference is not 














Figure 3. Effect of ethanol on incorporation of radioactivity 
into hepatic triglyceride in rats given glycerol-U<,L.-pl4. Each point 
represents the mean of results obtained in five animals.
* - Indicates that the difference between control and ethanol-















Figure 4. Effect of ethanol on incorporation of radioactivity 
into hepatic phosphatidylcholine and phosphatidylethanolamine in rats 
given glycerol-U.L.-CW. Each point represents the mean of results ob­
tained in five animals.
* - Indicates that the difference between control and ethanol-
treated groups was statistically significant (p < 0.02).
TABLE 6
EFFECT OF ETHANOL ON INCORPORATION OF RADIOACTIVITY INTO HEPATIC GLYCEROLIPIDS
IN RATS GIVEN GLYCEROL-U.L.-Cl^ a)
Duration Following Isotope Administration
0 to 45 min. 45 to 120 min. Total (O to 120 min.)
Control Ethanol Control Ethanol Control Ethanol
Triglyceride 57.28 90,16 67,76 105.52 125.04 195,68
Phosphatidylcholine 5.85 8,34 11,34 14.82 17.20 23.16
Phosphatidylethanolamine 1.26 2.00 3.28 3.07 4.54 5.07
ê
^Values, in square inches, were obtained by planimetric analysis of the area beneath the 
radioactivity incorporation curves (Figures 3 and 4) in which total radioactivity (dpm X 10-6) in each 
glycerolipid was plotted versus time.
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small peak was observed at 30 minutes in the incorporation curve for the 
ethanol-treated group (Fig. 4). Specific and total radioactivity values 
for this phospholipid were much lower in both groups during the 4-hour 
period of study than those observed for phosphatidylcholine. The total 
radioactivity incorporated into hepatic phosphatidylethanolamine during 
the first 2-hour period after isotope injection was slightly greater 
(9̂ ) in the ethanol-treated rats than in controls (Table 6).
Effect of Ethanol on Glvcerolipid Turnover 
Half-time values and turnover rates were calculated from radio­
activity incorporation curves for hepatic glycerolipids obtained follow­
ing the administration of glycerol-3-H^ to control and ethanol-treated 
rats (Table 7). The half-time for hepatic triglyceride in the control 
group (30 hours) was less than that for phosphatidylcholine (34 hours) 
and phosphatidylethanolamine (49 hours). Half-time values in the rats 
given ethanol were higher for hepatic triglyceride, slightly higher for 
phosphatidylcholine and slightly lower for phosphatidylethanolamine than 
were comparable values observed in controls. Ethanol increased the abso­
lute turnover rate (mg per day) of each glycerolipid (triglyceride by 
22̂  of control; phosphatidylcholine, 16%; and phosphatidylethanolamine, 
1C%) and the fractional turnover rate (percent per day) of phosphatidyl­
ethanolamine. Fractional turnover rates for triglyceride and phospha­
tidylcholine in ethanol-treated rats, however, were lower than in con­
trols.
Effect of Ethanol and Type of Dietary Fat on the Fatty Acid 
Composition of Hepatic and Adipose Tissue Glycerolipids
Hepatic triglyceride from control rats fed a diet containing
TABLE 7








Control Ethanol Control Ethanol Control Ethanol Control Ethanol to
Triglyceride 84.5+6.44 149.0+21.53 1.25 1.79 49 ,8 61 ,0 58.9 40 .9
Phosphatidylcholine 110.4+6.84 134,9+ 5,77 1.43 1.51 53,6 6 2 .0 48 ,5 45 .9
Phosphatidylethanolamine 57,7+3.51 56,6+ 1.95 2 .04 1.83 19.6 21 .5 34.0 38.0
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corn oil as the sole source of fat calories contained primarily palmitic, 
oleic and linoleic acid (Table 8). These three fatty acids comprise in 
excess of 95^ of the fatty acids present in corn oil (Table 2). Hepatic 
triglyceride from ethanol-treated rats fed corn oil contained a greater 
proportion of linoleic acid (p < 0.02) and a smaller proportion of myris- 
tic, palmitic (p < O.Ol), palmitoleic, stearic and oleic acid than con­
trols.
Substitution of coconut oil for corn oil produced a relatively 
large increase in the proportion of capric, lauric and myristic acid and 
a marked decrease in the proportion of linoleic acid in hepatic trigly­
ceride from controls (Table 8). Coconut oil contains more than 75%
%"^14 fatty acids and less than 2% linoleic acid (Table 2). Less pro­
nounced increases were observed in the two principal fatty acids (palmi­
tic and oleic acid) which are derived from endogenous synthesis. Hepatic 
triglyceride from ethanol-treated rats fed coconut oil contained a greater 
proportion of capric, lauric (p < 0.05), myristic (p < O.OOl) and palmit­
oleic acid and a smaller proportion of palmitic, stearic (p < O.Ol), 
oleic (p < 0.02) and linoleic acid than controls.
Fatty acid analysis of hepatic phosphatidylcholine from control 
rats fed a diet containing corn oil demonstrated primarily palmitic, 
stearic, linoleic and arachidonic acid (Tables 9-10). Hepatic phospha­
tidylcholine from ethanol-treated rats fed corn oil contained a greater 
proportion of stearic, oleic and arachidonic acid (p < O.OOl) and a 
smaller proportion of palmitic (p < O.OOl), palmitoleic and linoleic acid 
than controls. The hepatic content of only one of the phosphatidylcholine 
fatty acids, i.e., palmitoleic acid, was less in the ethanol-treated rats
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TABLE 8
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON PERCENT COMPOSITION 
OF INDIVIDUAL TRIGLYCERIDE-FATTY ACIDS IN LIVERS
Fatty Corn Oil^ Coconut Oil^
Acid Control Ethanol p' Control Ethanol P
^lOtO 0.0 0.0 0.540,44 0.840.34 ns
^12:0 0.140.60 0.0 ns 4.841.27 11.442.37 0.05
1̂4-. 0 0.740.12 0.440.03 ns 7.15). 74 16.441,37 0.001
^16:0 40.843.03 30.641.14 0.01 43.045.38 40.1%.00 ns
^16il 3.640.74 1.941.11 ns 4.740.89 5.441.09 ns
^18:0 2.740.57 i.:^.56 ns 3,0%.42 1.440.11 0.01
1̂8:1- 23.942.41 23.341.61 ns 30.544.65 20.^1,06 0.02
^18:2 28.344.10 42.841.65 0.02 6.141.19 3.840.48 ns
^Values are presented as percent of total, + standard error of
the mean.
^iets containing either corn oil or coconut oil were fed for
46 days.
''Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
^Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
^Statistical significance of difference between mean values ob­
tained in ethanol-treated and control groups ; ns indicates difference is 
not significant at 0.05 level.
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TABLE 8— Continued
Coconut Oil, then Corn Oil'- Corn Oil, then Coconut Oil*̂
Control Ethanol P Control Ethanol P
0.0 0.0 0.0 0.0
0.7+0.40 0.8+0.26 ns 2.3+0.93 5.^.20 ns
2.%0.67 2.^.13 ns 4.9+0.72 8.9+2.91 ns
41.3+4.34 37.8+3.75 ns 40.^.63 37.5+5.45 ns
4.0+0.38 3.7+0.67 ns 3.5+0.22 6.7+1.00 0.02
2.8+0.34 1.4+0.53 ns 11.6+2.64 4.3+0.72 0.05
30.4+1.92 28.3+1.42 ns 19.7+0.62 28.3+5.62 ns
18.0+1.11 25.6+2.84 0.05 17.%1.18 9.%1.56 0.01
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TABLE 9
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON PERCENT COMPOSITION 
OF INDIVIDUAL PHOSPHATIDYLCHOLINE-FATTY ACIDS IN LIVER®
Fatty
Acid
Corn Oil^ Coconut 011^
Control Ethanol Control Ethanol
^14:0 0.1+0.09 0.0 1.CW.24 1.6+0.22 ns
^16:0 34.4+0.17 25.6+1.41 0.001 49.9+4.12 50.3+2.64 ns
("16:1 2.3+0.99 0.9+0.33 ns 2.CHp.45 2.9+0.68 ns
("18:0 26.9+2.20 30.^.16 ns 25.3+2.28 24.0+2.57 ns
("18:1 6.3+0.48 7.1+0.86 ns 10.5+1.97 12.2+1.85 ns
(̂ 18:2 16.0+1.55 13.5+1.98 ns 5.9+0.73 3.5+0.65 0.05
("20:4 13.8+0.11 22.7+0.72 0.001 5.4+1.41 5.4+1.28 ns
the mean.
Values are presented as percent of total, + standard error of
46 days.
^iets containing either corn oil or coconut oil were fed for
Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
“̂Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
^Statistical significance of difference between mean values ob­
tained in ethanol-treated and control groups; ns indicates difference is 
not significant at 0.05 level.
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TABLE 9— Continued
Coconut Oil, then Corn Oil^ Corn Oil, then Coconut Oil*̂
Control Ethanol P Control Ethanol P
0.8+0.29 O.^.ll ns 1.4+0.19 1.5+0.18 ns
38.4+2.55 35.7+2.00 ns 33.3+3.06 28.2W.75 ns
1.4+0.20 1.0+0.19 ns . 2.1+0.51 2.3+0.42 ns
23.6+2.03 32.0+2.90 0.05 34.4+0.32 35.0+2.34 ns
7.^.53 6.4+0.46 ns 11.^1.53 13.6+1.14 ns
19.1+1.93 15.7+1.99 ns 7.%1.05 8.4+1.50 ns
8.7+1.09 9.1+1.18 ns 9.4+2.35 10.%2.20 ns
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TABLE 10
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON THE CONTENT OF 
INDIVIDUAL PHOSPHATIDYLCHOLINE-FATTY ACIDS IN LIVER®
Fatty
Acid
Corn Oil^ Coconut Oil^
Control Ethanol Control Ethanol
""14:0 0.^.23 0.0 2.6+ 0.60 5.6+0.90
^16:0 86.^.42 92.1+4.84 124.8+10.31 174.0+9.11
^16:1 5.8+2.50 3.1+1.14 5.0+ 1.15 10.0+2.35
Ci8:0 67.3+5.51 104.4+7.47 63.% 5.71 83.0+8.89
^18:1 15.9+1.20 24.6+2.97 26.% 4.93 42.0+6.40
("18:2 40.0+3.88 46.7+7.40 14.8+ 1.83 13.7+2.25
("20:4 34.6+2.83 78.4+2.49 13.4+ 3.53 18.6+4.39
®Values are presented as pmoles, + standard error of the mean. 
Results were calculated by multiplying the percent of individual fatty 
acid (Table 9) by the total pmoles of fatty acid in phosphatidylcholine.
^iet containing either corn oil or coconut oil was fed for 46
days.
''Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
'̂ Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
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TABLE 10— Continued
Coconut Oil, then Corn Oil^ Corn Oil, then Coconut Oil*̂
Control Ethanol Control Ethanol
1.9+0.74 5.9+ 0.62 3.6+0.48 5.:yp.62
96.1+6.33 123.5+ 6.92 83.4+7.66 97.4+2.59
3.6+0.50 3.5+ 0.66 5.3+1.28 8.1+1.45
59.1+5.08 110.5+10.03 86. ̂ . 8 0 121.0+8.09
19.5+1.33 22.1+ 1.59 28,1+3.83 47.1+3.94
47.8+4.83 54.3+ 6.88 19.9+2.6,3 . 29.^5.19
21,8+2.73 31.4+ 4.08 23.5+5.88 37.8+7.61
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given a diet containing corn oil than in controls (Table 10).
Hepatic phosphatidylcholine from rats fed coconut oil, compared 
with those fed corn oil, contained greater amounts of myristic, palmitic 
and oleic acid and smaller amounts of palmitoleic, stearic, linoleic and 
arachidonic acid. The magnitude of changes produced by ethanol in the 
fatty acid composition of hepatic phosphatidylcholine of coconut oil-fed 
rats was small. However, a slight increase in the mean values of myris­
tic, palmitic, palmitoleic and oleic acid and a slight decrease in stearic 
and linoleic (p < 0.05) acid was observed in ethanol-treated rats. The 
hepatic content of each phosphatidylcholine-fatty acid except linoleic 
acid was greater in the latter group of rats than in controls (Table 10).
The principal fatty acids found in hepatic phosphatidylethanol- 
amine and phosphatidylcholine of control rats fed corn oil were similar 
(Tables 11-12). Although ethanol produced no statistically significant 
change in the fatty acid composition of phosphatidylethanolamine in rats 
fed corn oil, a small decrease in the mean percentage of linoleic acid 
and a small increase in arachidonic acid were found. The hepatic content 
of each phosphatidylethanolamine-fatty acid was increased in ethanol- 
treated rats, except for palmitoleic acid which was unchanged and myris­
tic and linoleic acid which were decreased (Table 12). Hepatic phospha- 
tidylethanolamine from coconut oil-fed rats contained a greater propor­
tion of myristic, palmitic, palmitoleic and oleic acid and less stearic, 
linoleic and arachidonic acid than that from corn oil-fed rats (Table 11). 
Ethanol produced an increase in the relative amount of stearic acid and 
a small decrease in oleic and arachidonic acid, although none of these 
differences was statistically significant. The hepatic contents of pal-
51
TABLE 11
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON PERCENT COMPOSITION 
OF INDIVIDUAL PHOSPHATIDYLETHANOLAMINE-FATTY ACIDS IN LIVER®
Fatty
Acid
Corn Oil^ Coconut Oil^
Control Ethanol P® Control Ethanol P
Cl4:0 0.5±0.34 0,0 ns 1.1+0.63 0.^.18 ns
‘̂16:0 31.4+1.59 31.7+1.75 ns 44.8+1.90 43,4+1.41 ns
^16:1 1.0+0.21 0.8+0.34 ns 1.8+0.44 2.1+0.45 ns
^18:0 34.8+1.84 35.!^1.89 ns 30.3+3.78 37,7jp.61 ns
^18:1 7.1+0.39 7.4+0.73 ns 8.7+2.80 6.5+0.81 ns
Cl8:2 12.8+2.37 9.7+1,45 ns 3.8+1.49 3.4+0.78 ns
^20; 4 12.4+1.28 15.3+2.27 ns 9.3+2.48 6.^1.38 ns
^Values are presented as percent of total, + standard error of
the mean.
46 days.
^Diets containing either corn oil or coconut oil were fed for
^Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
^Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
^Statistical significance of difference between mean values ob­
tained in ethanol-treated and control groups; ns indicates difference is 
not significant at 0.05 level.
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TABLE 11— Continued
Coconut Oil, then Corn Oil*' Corn Oil, then Coconut Oil*̂
Control Ethanol P Control Ethanol P
0«7j^.29 0.6+0.23 ns 1.4+0.29 1.1+0.25 ns
37.0+1.88 34.5+2.20 ns 33.4+0.83 35.1+1.28 ns
2.0+0.25 0.9+0.40 0.05 2.:^.43 1.8+0.31 ns
29.9+2.32 40.0+1.67 0.01 31.%0.52 33.1+1.46 ns
7.7+1.45 4.4+0.66 ns 14.1+1.70 11.^.26 ns
11.8+1.75 5.5+1.21 0.02 6.1+0.59 5.9+1.03 ns
10.8+0.88 14.3+1.96 ns 11.4+0.89 11.5+2.60 ns
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TABLE 12
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON THE CONTENT OF 




Corn Oil^ Coconut Oil^
Control Ethanol Control Ethanol
^14:0 0.6+0.36 0.0 1.3+0.78 0.4+0.36
^16:0 37.3+1.95 49.0+2.71 54.%2.33 67.1+2.17
^16:1 l.%0.26 l.%0.52 2.:%0.54 3.3+0.69
^18:0 42.6+2.26 54.4+2.93 37,1+4.64 58.4+0.94
1̂8:1 8.7jp.49 11.^1.13 10.6+3.44 10.1+1.25
^18:2 15.8+2.91 15.0+2.25 4.7+1.83 5.3+1.20
^20:4 15.^1.57 23.7+3.50 11.5+3.04 10.1+2.13
Values are presented as pjnoles, + standard error of the me^n. 
Results were calculated by multiplying the percent of individual fatty 




Diet containing either corn oil or coconut oil was fed for 46
Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
^Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
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TABLE 12— Continued
Coconut Oil, then Corn Oil^ Corn Oil, then Coconut Oil^
Control Ethanol Control Ethanol
0.%0.36 0.9+0.36 1.8+0,36 1.8+0,39
45.5+2.31 53.3+3.40 41.0+1.02 54.4+1.98
2.5+0.31 1.4+0,62 2,7+0,53 2.8+0.48•r
36.8+2.85 61.8+2.58 38.3+0.64 51.%2.26
9.5+1.78 6.9+1.02 17.3+2.09 17,4+3.50
14.4+2.15 8.4+1,86 7.5+0.72 9.1+1.59
13.3+1.08 22,2+3.03 14.0+1.09 17.8+4.02
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mitic, palmitoleic, stearic and linoleic acid in phosphatidylethanolamine 
were increased in ethanol-treated rats fed coconut oil, whereas total 
amounts of myristic, oleic and arachidonic acid were decreased (Table 12).
Adipose tissue triglyceride from corn oil-fed rats contained 
primarily palmitic, oleic and linoleic acid (Table 13). Ethanol produced 
a decrease in the proportion of lauric (p < O.OOl), myristic (p < 0.05), 
palmitic (p < O.Ol) and palmitoleic acid (p < 0.05) and an increase in 
the relative amount of stearic, oleic and linoleic acid (p < 0.05). When 
coconut oil was the sole source of dietary triglyceride, lauric, myristic, 
palmitic and oleic acid were the principal fatty acids present in adipose 
tissue triglyceride. Substitution of coconut oil for corn oil increased 
the proportion of capric, lauric, myristic and palmitoleic acid and de­
creased the relative amount of palmitic, stearic, oleic and linoleic acid. 
Administration of ethanol to coconut oil-fed rats produced an increase in 
the proportion of capric and lauric acid (p < O.Ol) in adipose tissue tri­
glyceride and a decrease in myristic, palmitic, palmitoleic, stearic, 
oleic (p < 0.05) and linoleic acid.
Hepatic and adipose tissue glycerolipids were studied also in 
rats fed corn oil as the sole source of fat calories for 42 days, follow­
ed for the last 4 days prior to sacrifice by a diet containing coconut 
oil, or vice versa (Tables 8-13). Response of hepatic triglyceride, 
phosphatidylcholine and phosphatidylethanolamine to change in the fatty 
acid composition of the dietary triglyceride was clearly evident by the 
end of the 4-day period. A substantial decrease in the proportion of 
lauric acid and increase in linoleic acid were observed in hepatic tri­
glyceride from controls in which corn oil was substituted for coconut
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TABLE 13
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON PERCENT COMPOSITION OF 




Corn Oil^ Coconut Oil^
Control Ethanol P" Control Ethanol P
^10:0 0.0 0.0 0.5+0.03 0.7+D.05 ns
^12:0 0.2+0.01 0.1+0.01 0,001 28.5+2.16 51.5+3.62 0.01
^14:0 2.0+0.14 1.5+0.08 0.05 14,8+1.12 13.3+0.88 ns
^16:0 33.^1,21 25.5+1.04 0.01 22.7+1.88 16.0dp.94 ns
^16:1 6.4+0.47 4.1+0.67 0.05 6.9+0.37 2.5+2.19 ns
Cl8:0 2.6+0.43 3.^0.56 ns 2.0+0.30 1.3+0.58 ns
('18:1 27.%0.59 32.4+1.89 ns 21.7+1,28 12.9+2.14 0.05
('18:2 27.7+1.63 32.9+1.16 0.05 2.8+0.37 1.5+0.92 ns
^Values are presented as percent of total, + standard error of
the mean. 
46 days.
^Diets containing either corn oil or coconut oil were fed for
''Diet containing coconut oil was fed for 42 days, followed by 
one containing corn oil for 4 days.
'̂ Diet containing corn oil was fed for 42 days, followed by one 
containing coconut oil for 4 days.
®Statistical significance of difference between mean values ob­
tained in ethanol-treated and control groups; ns indicates difference is 
not significant at 0.05 level.
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TABLE 13— Continued
Coconut Oil, then Corn Oil*̂ Corn Oil, then Coconut Oil*̂
Control Ethanol P Control Ethanol P
0.0 7.1+0.17 0.0 0,0
31.1+5.64 37.0+0.87 ns 14.2+1.39 11,7+1.47 ns
10.7+1.95 10.8+0.25 ns 6.7+0.65 5.5+3.69 ns
22.8+2.19 15.6+1.63 0.05 24.0+1.08 20.%1.17 0.05
4.9+0.67 2.8+0.35 0.05 3.7+0.50 3.3+0.38 ns
2.^.28 1.6+0.27 ns 2.3+0.18 1.9+0.22 ns
20.9+3.26 17.8+0.90 ns 24.0+0.86 25.^.74 ns
7,4+2.56 6.5+1.53 ns 25.1+2.38 32.6+1.51 0.05
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oil, when conçared with results obtained in controls given coconut oil 
throughout the study. An opposite pattern of change in the fatty acid 
composition of hepatic triglyceride, characterized by a marked decrease 
in the proportion of linoleic acid and increase in lauric acid, was ob­
served when the results obtained in controls in which coconut oil was 
substituted for corn oil were compared with those obtained in controls 
given corn oil throughout the study. Similar comparisons of the propor­
tions of linoleic and arachidonic acid, individually or as the sum of the 
percentages of these fatty acids, in hepatic phosphatidylcholine and 
phosphatidylethanolamine demonstrated that these values were increased 
in controls in which corn oil was substituted for coconut oil and de­
creased when corn oil was replaced by coconut oil. The proportions of 
lauric and linoleic acid in hepatic triglyceride from ethanol-treated 
rats resembled the fatty acid composition of the diet to a greater degree 
than those from controls. Ethanol failed to produce a similar consist­
ent effect, in response to the fatty acid composition of diet, on the 
proportions of linoleic and arachidonic acid in hepatic phosphatidyl­
choline and phosphatidylethanolamine.
The lauric and linoleic acid composition of adipose tissue tri­
glyceride also was altered within a 4-day period after the fatty acid 
composition of the diet was modified, but the magnitude of the response 
was generally much less than that observed in hepatic triglyceride. The 
proportions of these two fatty acids in adipose tissue triglyceride from 
controls resembled the fatty acid composition of the diet to a greater 
degree than those in adipose tissue triglyceride from ethanol-treated 
rats.
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Effect of Ethanol and Type of Dietary Fat on Fatty 
Acvl-Coenzyme AtLvsophbsphaitide Transferase 
Activities in Rat Liver Microsomes
Transferase activities in liver microsomes from rats fed a diet 
containing corn oil were assayed using the CoA-derivative of palmitic, 
stearic, oleic, linoleic or arachidonic acid as fatty acid donor and cl­
o t  p-iysophosphatidyichoiine as fatty acid acceptor. When a-lysophospha- 
tidylcholine served as acceptor, much higher transferase activities were 
observed with oleic, linoleic and arachidonic acid than with palmitic and 
stearic acid (Table 14). The transferase activities observed when p- 
lysophosphatidylcholine was used as acceptor were highest with palmitic 
acid, intermediate with stearic and oleic acid and lowest with linoleic 
and arachidonic acid. These results are consistent with observations re­
ported by others (159-162), indicating that saturated fatty acids are 
esterified preferentially at the a-position of phosphatidylcholine and 
phosphatidylethanolamine, and unsaturated fatty acids at the p-position. 
Ethanol produced a substantial increase in activities for transfer of 
oleic, linoleic and arachidonic acid onto c-lysophosphatidylcholine, but 
had little effect on the transfer of stearic and palmitic acid onto this 
substrate. The sum of the activities for transfer of unsaturated fatty 
acids onto a-iysophosphatidylcholine was much greater in ethanol-treated 
rats, whereas this value for saturated fatty acids was essentially un­
changed. Ethanol decreased the transferase activities for palmitic and 
stearic acid onto p-lysophosphatidylcholine, but produced only a small and 
inconstant effect on the activities for the unsaturated fatty acids stud­
ied. A pronounced decrease was observed in the sum of the activities for 
transfer of saturated fatty acids onto p-lysophosphatidylcholine in
TABLE 14
EFFECT OF ETHANOL AND TYPE OF DIETARY FAT ON FATTY ACYL-COENZYME A:LYSOPHOSPHATIDYLCHOLINE
TRANSFERASE ACTIVITY IN RAT LIVER MICROSOMES®
Diet FattyAcid
a-Lysophosphatidylcholine p-Lysophosphatidylcholine
Control Ethanol Control Ethanol
Total (a + p)
Control Ethanol
^1610 17.7+ 3.69 16.3+ 1.11 66.5+ 7.30 36.9+ 9.99 84.2 53.2
#-H GlSiO 5.5+ 1.26 8.7+ 3.57 33.3+10.20 21.6+ 4.09 38.8 30.3
o ^18:1 61.5+14.31 108.3+14.17 26.1+ 4.36 21.5+ 5.62 87.6 129.8
1 Ci8:2 55.5+ 4.72 95.3+23.51 5.5+ 1.75 10.5+ 3.12 61.0 105.8
^20:4 50.2+ 7.37 87.7+17.28 8.5+ 3.80 4.2+ 1.07 58.7 91.9
^16.0 17.1+ 1.33 9.1+ 1.35 56.0+ 8.71 55.6+ 7.41 73.1 64.7
•Ho CiesO 4.2+ 1.04 0.8+ 0.04 34.8+ 3.07 46.0+10.91 39.0 46.8
4->
g ("18:1 64.9+ 6.81 76.5+ 7.39 27.1+ 5,85 26.5+ 4.15 92.0 103.0Oo
cS Cl8t2 56.6+ 8.29 49.9+ 1.94 10.9+ 2.18 20.4+ 3.99 67.5 ' 70.3
("20:4 27.0+ 6.05 24.6+ 6.02 4.1+ 1.19 11.3+ 2.18 31.1 35.9
o\o
®Values are expressed as mjimoles of CoA released per minute per mg of microsomal protein, + 
standard error of the mean.
*^Substrate used as fatty acid acceptor.
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ethanol-treated rats fed corn oil, while little change was observed in 
this value for unsaturated fatty acids « The sum of activities for trans­
fer of all fatty acids onto c-iysophosphatidylcholine was increased in 
ethanol-treated rats fed corn oil, whereas this value for p-lysophospha- 
tidylcholine was decreased. Total transferase activities (the sum of 
the activities for transfer of individual fatty acids onto a- and p- 
lysophosphatidylcholine) in ethanol-treated rats were decreased for sat­
urated fatty acids (palmitic and stearic acid) and increased for unsat­
urated fatty acids (oleic, linoleic and arachidonic acid). The sum of 
total transferase activities for saturated fatty acids was less and that 
for unsaturated fatty acids was much greater in these ethanol-treated 
rats. Ethanol produced a moderate increase in the sum of the total trans­
ferase activities for all fatty acids in rats fed corn oil.
Transferase activities using a- and p-lysophosphatidylcholine 
as acceptors were also assayed in liver microsomes obtained from rats fed 
coconut oil (Table 14). Results for control rats fed coconut oil were 
similar to those for controls fed corn oil, with the exceptions that the 
activities for transfer of arachidonic acid onto a-lysophosphatidylcholine 
was much lower in the coconut oil-fed rats. Ethanol produced much less 
effect on the activities for transfer of fatty acids onto a- or p-lyso- 
phosphatidylcholine in liver microsomes from rats fed coconut oil than 
from those fed corn oil. However, small decreases in activities, relative 
to control values, were observed for the transfer of palmitic, stearic, 
linoleic and arachidonic acid onto a-lysophosphatidylcholine and for the 
transfer of stearic, linoleic and arachidonic acid onto p-lysophospha- 
tidylcholine in ethanol-treated rats fed coconut oil. The sum of the
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activities for transfer of saturated fatty acids onto a-lysophosphatidyl­
choline was decreased slightly in ethanol-treated rats, while this value 
for unsaturated fatty acids was unchanged» Ethanol produced a small in­
crease in the sum of the activities for transfer of saturated and unsat­
urated fatty acids onto p-lysophosphatidylcholine. The sum of the activ­
ities for transfer of all fatty acids onto a-lysophatidylcholine was es­
sentially unchanged in ethanol-treated rats fed coconut oil, whereas this 
value for p-lysophosphatidylcholine was moderately increased. The sum _ 
of the total transferase activities for unsaturated fatty acids was in­
creased slightly in ethanol-treated rats, whereas no difference was ob­
served for saturated fatty acids. When the sum of total transferase ac­
tivities for all fatty acids was calculated, the value obtained in 
ethanol-treated rats fed coconut oil was only slightly greater than the 
control value. Thus, ethanol had much less effect on this value in rats 
fed coconut oil than in those fed corn oil»
Transferase activities in liver microsomes from rats fed a diet 
containing corn oil were assayed using a- and p-lysophosphatidylethanol- 
amine as acceptors (Table 15). In controls, activities for transfer of 
linoleic and arachidonic acid onto a-lysophosphatidylethanolamine were 
higher than those for the other three fatty acids studied. The highest 
activity for fatty acid transfer onto p-lysophosphatidylethanolamine in 
these rats was observed with palmitic acid. Intermediate values, were ob­
tained with linoleic and arachidonic acid and lowest values with stearic 
and oleic acid. The activities for transfer of each fatty acid onto a- 
lysophosphatidylethanolamine were higher in ethanol-treated rats than in 
controls, although the magnitude of this increase was small. When com-
TABLE 15
EFFECT OF ETHANOL ON FATTY ACYL-COENZYME A:LYSOPHOSPHATIDYLETHANOLAMINE 
TRANSFERASE ACTIVITY IN RAT LIVER MICROSOMES^
Fatty
Acid
a-Lysophosphatidylethanolamine^ p-Lysophosphatidylethanolamine^ Total (a + p)
Control Ethanol Control Ethanol Control Ethanol
^16:0 4.0+1.24 7.4+1.37 21.3+3.65 15.0+3.74 25.3 22.4
*̂ 18*0 1.6+0.41 8.2+1.26 4.2+0.85 14.8+3.55 5.8 23.0
"̂ 18:1 6.0+1.99 12.8+1.56 4.4+1.50 6.0+2.61 10.4 18.8
^16*2 10.8+3.13 15.2+1.91 10.1+3.22 11.6+3.80 20.9 26.8
^20*4 13.0+3.19 14.6+2.64 7.7+2.45 2.6+0.67 20.7 17.2
Fatty acyl-CoA*lysophosphatidylethanolamine transferase activity was measured only in rats 
fed corn oil. Values are expressed as mpmoles of CoA released per minute per mg of microsomal protein, 
+ standard error of the mean.
^Substrate used as fatty acid acceptor.
ONCO
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pared with values obtained in controls, the sum of the activities for 
transfer of fatty acids onto a-lysophosphatidylethanolamine in ethanol- 
treated rats was slightly increased for saturated and unsaturated fatty 
acids. Activities for transfer of stearic, oleic and linoleic acid onto 
p-lysophosphatidylethanolamine in ethanol-treated rats were slightly 
greater than in controls, whereas slightly lower activities were observed 
for palmitic and arachidonic acid. Ethanol treatment had little effect 
on the sum of activities for transfer of either saturated or unsaturated 
fatty acids onto p-lysophosphatidybethanolamine. The sum of the activ­
ities for the transfer of all fatty acids onto a-lysophosphatidylethanol­
amine was somewhat greater in ethanol-treated rats than in controls, 
whereas little change was observed in this value when p-lysophosphatidyl- 
ethanolamine served as acceptor. In ethanol-treated rats, total trans­
ferase activities for palmitic and arachidonic acid were decreased and 
those for stearic, oleic and linoleic acid were increased. Ethanol in­
creased the sum of total transferase activities for saturated and for un­
saturated fatty acids. The sum of total transferase activities for all 
fatty acids was higher in ethanol-treated rats than controls.
Effect of Ethanol on Fatty Acvl-Coehzyme A Hydrolase 
Activities in Rat Liver Microsomes
Hydrolase activities in liver microsomes from rats fed corn oil 
were higher with palmitic, linoleic and arachidonic acid than with oleic 
acid and stearic acid (Table 16). Ethanol administration produced a 
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*̂ 20:4 12.5+1.65 17.3+1.42
^Values are expressed as mjimoles of CoA released per minute per 
mg of microsomal protein, + standard error of the mean.
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Comparison of Fatty Acid Composition of Hepatic 
Phosphatides with Hepatic Microsomal Fatty 
Acvl-Coenzvmè A;LvsophospKatide 
Transferase Activities
Relative microsomal activities for the transfer of palmitic, 
stearic, oleic, linoleic and arachidonic acid onto lysophosphatidyl- 
choline were calculated for comparison with the fatty acid distribution 
in phosphatidylcholine (Table 17). In liver from rats fed the diet con­
taining corn oil, the relative transferase activity values were lower for 
saturated fatty acids (palmitic and stearic acid) and higher for unsat­
urated fatty acids (oleic, linoleic and arachidonic acid) than the per­
centages of these fatty acids in phosphatidylcholine. Ethanol accentu­
ated the disparity between relative transferase activities and the fatty 
acid composition of phosphatidylcholine for all fatty acids except arach­
idonic acid. In ethanol-treated rats, values obtained for relative 
transferase activity with arachidonic acid and for the percentage of this 
fatty acid in phosphatidylcholine were similar.
The relationship between relative transferase activities with 
lysophosphatidylethanolamine and the fatty acid distribution of phospha­
tidylethanolamine was similar generally to that between relative trans­
ferase activities with lysophosphatidylcholine and the fatty acid distri­
bution of phosphatidylcholine (Table 18). Relative activities for the 
transfer of the series of fatty acids onto lysophosphatidylethanolamine 
were lower for saturated fatty acids and higher for unsaturated fatty 
acids than the percentages of these fatty acids in phosphatidylethanol­
amine. Ethanol produced an increase in the difference between these two 
values for palmitic, oleic and linoleic acid and a decrease in that for 
stearic and arachidonic acid.
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TABLE 17
COMPARISON OF THE FATTY ACID COMPOSITION OF HEPATIC PHOSPHATIDYLCHOLINE 















Cl6:0 34.4 25.5 25.6 12.9
^16:1 2.3 d 0.9 d
^18:0 26.9 11.7 30.2 7.4
Cl8:l 6.3 26.5 7.1 31.6
Cl8:2 16.0 18.5 13.5 25.7
^20; 4 13.8 17.8 22.7 22.4
^Results were obtained from rats fed a diet containing corn oil.
^Values are expressed as percent of the total fatty acid conpo-
sition of phosphatidylcholine, determined by gas-liquid chromatography.
^Values are expressed as percent of total transferase activity,
calculated for each fatty acid as the sum of the activities observed
when a- and p-lysophosphatidylcholines were used as substrates.
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^16:0 31.4 30.4 31.7 20.7
^16:1 1.0 d 0.8 d
^18:0 34.8 7.0 35.2 21.3
Cl 8:1 7.1 12.5 7.4 17,3
ClB:2 12,8 25.2 9.7 24.8
^20:4 12.4 24.9 15.3 15.9
^Results were obtained from rats fed a diet containing corn oil.
^Values are expressed as percent of total fatty acid composi­
tion of phosphatidylethanolamine, determined by gas-liquid chromatog­
raphy.
^Values are expressed as percent of total transferase activity, 
calculated for each fatty acid as the sum of the activities observed 
when a- and p-lysophosphatidylethanolamines were used as substrates.




Results obtained in the present study demonstrate that chronic 
administration of ethanol to rats produces significant changes in liver 
lipids, including marked increases in triglyceride and esterified choles­
terol and moderate increases in free cholesterol, phosphatidylcholine, 
phosphatidylethanolamine and sphingomyelin. Other investigators have re­
ported that increased amounts primarily of triglyceride and esterified 
cholesterol may accumulate in the fatty liver produced by ethanol (128, 
129), although the magnitude of change appears to be influenced by the 
type and amount of fat in the diet (163-166) and by the amount of etha­
nol given and the duration of its administration (128, 142, 143).
Mechanisms Responsible for Lipid 
Accumulation in Liver
Mechanisms which may produce lipid accumulation in the liver in­
clude increased hepatic lipogenesis, decreased lipoprotein formation or 
release by liver and decreased hepatic oxidation of lipid. Results ob­
tained in the present study and those reported by other investigators per­
mit some evaluation of the relative importance of these mechanisms in the 
pathogenesis of the fatty liver produced by ethanol. Emphasis in the 
discussion which follows is focused on the effects of ethanol on the me­
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tabolism of hepatic triglyceride, phosphatidylcholine and phosphatidyl­
ethanolamine.
Effect of Ethanol on Hepatic Lipogenesis 
The fatty acids incorporated into hepatic glycerolipids may be 
derived either from ̂  novo fatty acid synthesis in liver or from dietary 
and adipose tissue triglyceride.
Evidence favoring the conclusion that ethanol may increase the 
rate of ̂  novo synthesis of fatty acids in liver has been obtained from 
studies of precursor incorporation into liver lipids. Ethanol stimulates 
the incorporation of radioactivity from acetate-C^^ into liver lipids in 
vivo (167) and into fatty acids of liver slices (168). Scheig and 
Isselbacher (169) also found that the jji vitro addition of ethanol to rat 
liver slices enhanced free fatty acid, triglyceride and phospholipid syn­
thesis from acetate-Ĉ '̂ *' and pyruvate-C^^, although they observed only a 
moderate increase in the radioactivity incorporated from these precursors 
into triglyceride and a decrease in that incorporated into phospholipid 
in liver slices from rats given a single dose of ethanol in vivo 16 hours 
prior to sacrifice.
The rate of fatty acid synthesis in liver may be accelerated
following ethanol treatment as a result of an increase in available ace­
tate (170) and NADH (167, 168, 171-174). The influence of increased 
levels of NADH on fatty acid synthesis might be expected to involve pri­
marily elongation of fatty acid chain length (175) and formation of un­
saturated fatty acids (l76, 177), rather than ̂  novo synthesis. The 
latter appears to require NADPH in preference to NADH as the hydrogen 
donor (173). It should be noted, however, that an increase in hepatic
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NADH content similar to that observed when ethanol is given has been de­
scribed in animals following the administration of sorbitol, xylitol, 
glucose, or fructose (134), although none of these sugars produces an ac­
cumulation of lipids in the liver.
Howard and Lowenstein (178) have shown that the availability of 
a-glycerophosphate influences the rate of fatty acid synthesis, and pre­
sumably that of glycerolipid formation, in microsomal preparations from 
rat liver. Nikkila and Ojala (146, 148) observed that the hepatic a- 
glycerophosphate consent was increased in ethanol-treated rats. These 
investigators and others (169) demonstrated an increased incorporation 
of palmitate-C^^ into hepatic triglyceride and phospholipid in ethanol- 
treated rats and concluded that this increase in palmitate-C^^ incorpora­
tion, as well as that of acetate-Ĉ '̂  and pyruvate-C^^, may result from 
increased hepatic a-glycerophosphate levels in these animals (146).
Fatty acids mobilized from adipose tissue and transported in 
the plasma provide a second major source of fatty acids available to the 
liver for estérification into glycerolipids. Increasing the rate of 
fatty acid mobilization from peripheral sites by administration of nor­
epinephrine to rats has been shown to lead to development of fatty liver 
(179). Evidence has been presented suggesting that adipose tissue tri­
glycerides may be the principal source of fatty acids accumulating in the 
fatty liver produced by a single large dose of ethanol (163, 169, 180, 
181). Under these conditions, the fatty acid composition of hepatic tri­
glyceride resembles that of adipose tissue rather than that expected from 
endogenous synthesis (l8l). Several investigators have reported that 
plasma FFA levels were elevated following large amounts of ethanol given
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as a single dose or within a period of several hours, suggesting that 
ethanol increased fatty acid mobilization from adipose tissue (125, 138, 
139, 182)o Additional evidence favoring this conclusion is the observa­
tion that fat accumulation in liver following alcohol administration may 
be prevented by hypophysectomy (l31, 167), adrenalectomy (125, 131), 
cordotomy (l67), or administration of ganglionic-blocking agents (l82). 
Other investigators, however, have found either no change (180, 183) or 
a decrease in plasma FFA levels, a decrease in plasma glycerol concentra­
tion, a reduction in plasma FFA turnover (137, 184-186) and no evidence 
of enhanced mobilization of fatty acids from labeled epididymal fat pads 
(IBO), following an acute episode of alcohol ingestion. In subjects 
given ethanol over short periods of time and studied by hepatic vein 
catheterization, net hepatic uptake was reduced (187). The apparent in­
consistencies in these results may reflect a dose response of FFA metab­
olism to the amount of ethanol administered. In addition, the possibil­
ity cannot be excluded that ethanol, under these conditions, may alter 
hepatic metabolism of FFA, thereby increasing their utilization for tri­
glyceride formation.
Results obtained in the present study and those reported by 
others (188-190) favor the conclusion that fatty acids derived from diet 
provide the majority of the triglyceride-fatty acids present in the fatty 
liver produced by chronic ethanol administration. Results presented here 
indicate that the oleic and linoleic acid composition of hepatic trigly­
ceride and, to a lesser extent, that of hepatic phosphatidylcholine and 
phosphatidylethanolamine resembled the fatty acid composition of the diet 
to a greater extent than the fatty acid composition of mesenteric adipose
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tissue. Other investigators have reported that the fatty acid composition 
of hepatic triglyceride in the fatty liver produced by prolonged ethanol 
ingestion resembled that found in dietary triglyceride but not that of 
depot fat when a diet containing fat was fed (l63, 164, 188-190). The 
fatty liver produced in ethanol-treated animals fed a fat-free diet or 
one containing triglycerides of medium-chain length fatty acids (predom­
inantly Cg and C^q) as the sole source of fat contained much less lipid 
than was observed when a more nearly normal amount and type of dietary 
fat was fed (129, 163, 191). The hepatic triglyceride-fatty acids found 
in the ethanol-treated rats fed a low-fat or fat-free diet were primarily 
those which may be synthesized endogenously rather than those present in 
the adipose tissue (l63, 191).
The mechanism whereby dietary triglyceride-fatty acids are uti­
lized for glycerolipid synthesis in preference to fatty acids derived 
from adipose tissue in animals administered ethanol chronically has not 
been defined. The possibility that ethanol might alter gastrointestinal 
absorption, or hepatic uptake of triglyceride has been investigated.
Ethanol had no effect on absorption of C^^-palmitate (l63), but produced 
a decrease in xylose absorption (192, 193). Uptake of ^-labeled chylo­
microns by the liver was not altered by ethanol (124, 163).
The majority of studies of the effect of ethanol on hepatic 
lipids have been concerned with changes produced in triglyceride, rather 
than those in phospholipid. The present study and those reported by 
others (l28, 129) have demonstrated that the magnitude of increase in 
hepatic phospholipid produced by ethanol is much less impressive than 
that found in triglyceride. Maling, Wakabayashi and Horning (194) and
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Scheig and Isselbacher (195) have reported that the incorporation of 
palmitate-Ĉ '̂  and acetate-Ĉ '̂  into phospholipid is decreased, whereas 
that into triglyceride is increased, in liver slices and homogenates from 
rats given a single dose of alcohol. However, studies involving intact 
animals have shown that incorporation of radioactivity from palmitate-C^^ 
into both hepatic triglyceride and phospholipid is increased in ethanol- 
treated rats, although much greater amounts of radioactivity were gen­
erally incorporated into triglyceride than phospholipid (146, 148). In 
these studies, the radioactivity incorporated into hepatic triglyceride 
in ethanol-treated rats was increased severalfold, when compared with 
controls, whereas only a slight increase was found in the radioactivity
present in hepatic phospholipid.
14 oGlycerol-C and glycerol-H'̂  were selected for the present study
in preference to labeled fatty acids and related precursors since other 
investigators have shown that less evidence of re-cycling is observed 
with glycerol (l96). Results obtained in the present study indicate that 
the total radioactivity from glycerol-C^^ incorporated into hepatic tri­
glyceride in the control group of rats was approximately seven-fold 
greater than that incorporated into phosphatidylcholine and approximately 
25-fold greater than into phosphatidylethanolamine during the first two 
hours following isotope injection. Ethanol produced an increase, rela­
tive to control values, in the total radioactivity incorporated into each 
of these glycerolipids. The greatest ethanol-induced increase was found 
in triglyceride and the least in phosphatidylethanolamine.
Results from the present study also indicate that the absolute 
turnover rates (mg per day) of hepatic phosphatidylcholine in control and
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ethanol-treated rats are slightly higher than those of hepatic triglycer­
ide. Each of these values for triglyceride and phosphatidylcholine in 
control and ethanol-treated rats is much higher than those observed for 
hepatic phosphatidylethanolamine. Nevertheless, during the 4-hour inter­
val following glycerol-Ĉ *̂  administration the specific and total radioac­
tivities of hepatic triglyceride were much greater than those of phos­
phatidylcholine, which has relatively similar turnover rates. One expla­
nation of these observations is that a significant portion of the hepatic 
triglyceride formed during the 4-hour period of this experiment may be 
synthesized using glycerol-C^^ derived from a pool distinct from that 
utilized for phosphatidylcholine synthesis.
Results obtained using labeled glycerol may infer erroneously 
low rates of glycerolipid synthesis, since an increased hepatic concen­
tration of a-glycerophosphate has been found in ethanol-treated rats 
(146) and the glycerol uptake by splanchnic organs has been found to be 
reduced following ethanol administration (197).
Effect of Ethanol on Release of 
Lipoproteins by Liver
Low plasma lipid concentrations have been observed in associa­
tion with the fatty liver produced by several agents vriiich impair hepatic 
protein synthesis, including carbon tetrachloride (97-102), ethionine 
(104-107), puromycin (108) and orotic acid (109, 110). Evidence of im­
paired lipoprotein release has been obtained from liver perfusion studies 
in Wiich palmitate-C^^ was used, although the physiological significance 
of this study is questionable due to the high concentrations of ethanol 
to which the organ was subjected (198). Other investigators have con-
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eluded that ethanol administered in vivo has no effect on lipoprotein syn­
thesis in liver (l03, 138). Results obtained in the present study favor 
the latter conclusion, since the concentration of each of the serum lipids 
was increased in ethanol-treated rats. A similar response in serum lipid 
concentrations to ethanol has been observed by other investigators in 
studies involving laboratory animals (l36) and human subjects (l33, 184).
The possibility exists that ethanol-induced elevations in serum 
lipid levels may reflect impaired removal of triglyceride and other lipids 
from blood. Measurements of plasma post-heparin lipoprotein lipase ac­
tivities have generally demonstrated normal levels following ethanol ad­
ministration (199, 200), although low values of this lipolytic activity 
have been described in six of a group of eight chronic alcoholics studied 
following a drinking bout (133). In addition, plasma obtained from a 
chronic alcoholic in whom lipemia and pancreatitis were observed follow­
ing an episode of acute alcoholism, was found to inhibit plasma post­
heparin lipoprotein lipase activity from a normal subject (201). Stud­
ies performed in human subjects fed a fat load have demonstrated that 
ethanol increases the lipemia (199). The possibility that ethanol alters 
lipolytic enzymes other than those appearing in plasma after heparin ad­
ministration has not been excluded by these studies.
Effect of Ethanol on Fatty Acid 
Oxidation by Liver
Wooles (202) studied fatty acid metabolism following the admin­
istration of a single large dose of ethanol to rats and concluded from 
indirect in vivo measurements that oxidation of hepatic fatty acids was 
depressed. Addition of ethanol to rat liver homogenates decreased the
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rate of palmitate-C^^ oxidation to radioactive carbon dioxide (167). 
Ethanol also depressed the oxidation of octanoate-C^^ to carbon dioxide 
in liver slices and liver perfused in vitro, although oxidation of this 
medium chain-length fatty acid was less inhibited than was palmitate 
(191).
Lieber and Schmid (168) have proposed that the high intracellu­
lar concentration of NADH in liver may decrease the rate of substrate 
oxidation via the citric acid cycle and thereby limit the conversion of 
fatty acid to carbon dioxide. The significance of any impairment in 
fatty acid oxidation produced by ethanol in relation to the development 
of fatty liver remains to be defined, since inhibition of fatty acid oxi­
dation similar to that produced by ethanol has been observed following 
the administration of several other substances, including sorbitol, 
xylitol, nicotinamide and isocaloric amounts of glucose, without evidence 
in any of the latter instances of fat accumulation in the liver (167).
Effect of Ethanol on Fattv Acid Composition 
of Hepatic Glycerolipid
Results obtained in the present study demonstrate that the fatty 
acid composition of hepatic triglyceride, phosphatidylcholine and phos­
phatidylethanolamine may be modified by altering the fatty acids present 
in dietary triglyceride from a saturated (approximately 92% of the fatty 
acids in coconut oil are saturated) to an unsaturated type (approximately 
8 ^  of the fatty acids in corn oil are unsaturated). A larger proportion 
of saturated fatty acids in each of these glycerolipids was found in 
liver from rats fed coconut oil, when compared with results obtained in 
rats fed corn oil.
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Triglyceride-fatty acids from ethanol-treated rats fed corn oil 
were relatively less saturated (decrease in saturated fatty acids from 
44.3 to 32.2^ of total) than controls, whereas triglyceride-fatty acids 
from ethanol-treated rats fed coconut oil were relatively more saturated 
(increase from 58.4 to 70.1%). These results and those reported by other 
investigators (l63) demonstrate that the fatty acid composition of the 
triglyceride which accumulates in the fatty liver produced by prolonged 
ethanol administration resembles, in part, dietary triglyceride. A sim­
ilar response to ethanol was observed in hepatic phosphatidylcholine from 
rats fed corn oil. Although the magnitude of the response to ethanol was 
less, statistically significant changes (decrease in the proportion of 
palmitic acid and increase in arachidonic acid) were observed in phospha­
tidylcholine-fatty acids from these animals. Ethanol had little effect 
either on the proportions of individual fatty acids or on the total pro­
portion of saturated fatty acids in phosphatidylcholine from rats fed 
coconut oil. A similar lack of response was observed in phosphatidyl­
ethanolamine from ethanol-treated rats fed either corn oil or coconut
oil.
The changes in fatty acid composition of hepatic glycerolipids, 
particularly triglyceride and phosphatidylcholine, observed in ethanol- 
treated rats might possibly reflect ethanol-induced alterations in the 
fatty acid composition of the diglyceride which is considered to be a com­
mon precursor in the synthesis of triglyceride, phosphatidylcholine and 
phosphatidylethanolamine. Zakim (203) has reported that ethanol lowers 
the hepatic concentration of long-chain acyl-CoA derivatives. If the 
concentration of acyl-CoA were limiting in liver of ethanol-treated rats.
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it is conceivable that a greater proportion of the fatty acids utilized 
for synthesis of the diglyceride intermediate, and other glycerolipids 
formed therefrom, might be derived from the fatty acids provided in die­
tary triglyceride. Results reported by Lands and Hart (74), however, 
demonstrated that stearic and linoleic acid were esterified at both the 
a- and p-position of glycerophosphate. This observation suggests that 
the acyltransferases involved in the formation of .phosphatidic acid and, 
subsequently, the diglyceride intermediate, are not sufficiently specific 
to account for the relative distribution of saturated and unsaturated 
fatty acids found in glycerolipids. Additional evidence favoring the 
conclusion that other factors are involved in the ethanol-induced effects 
on glycerolipid metabolism is the observation, obtained in the present 
study, that ethanol altered the fatty acid composition of hepatic tri­
glyceride and phosphatidylcholine to a much greater extent than that of 
phosphatidylethanolamine.
The possibility exists that ethanol might alter the activity of 
the transferases involved in the reaction of diglycerides with acyl-CoA, 
CDP-choline or CDP-ethanolamine. Goldman and Vagelos (67) have observed 
evidence of fatty acid specificity, in respect to both the diglyceride 
and acyl-CoA substrates, in the transferase activity vrfiich catalyzes the 
acylation of diglyceride to form triglyceride. The effect of ethanol, if 
any, on this group of transferases has not been evaluated.
Lands and co-workers (72, 74, 75) have presented evidence favor­
ing the conclusion that the characteristic fatty acid compositions of 
phosphatidylcholine and phosphatidylethanolamine are determined in a sig­
nificant degree Joy a re-distribution of fatty acids after the nitrogenous
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base has been attached to the molecule. This re-structuring of phospho­
lipids is catalyzed apparently by a group of fatty acyl-CoA:lysophospha- 
tide transferases found in liver microsomes. This group of investigators 
(204) has also shown that acyltransferase activities measured in vitro 
correlate favorably with the distribution of fatty acids, particularly 
the relative positional specificity of saturated and unsaturated fatty 
acids between the cl-  and ^-positions of glycerol, in glycerolipids in 
vivo.
Results obtained in the present study indicate that the activi­
ties of those acyltransferases for which a-lysophosphatidylcholine and 
û-lysophosphatidylethanolamine serve as acyl acceptors were increased 
in ethanol-treated rats fed corn oil. The fatty acyl specificities of 
the acyltransferase activities for a-lysophosphatidylcholine, however, 
differed from those for a-lysophosphatidylethanolamine. Ethanol produced 
a marked increase in the rate at which unsaturated fatty acids were 
transferred onto a-lysophosphatidylcholine, while the rate of transfer 
of saturated fatty acids was unchanged. When a-iysophosphatidylethanol- 
amine served as acceptor, the rate of transfer of both saturated and un­
saturated fatty acids was moderately increased. Ethanol had less effect 
on the acyltransferase activities for which p-lysophosphatidylcholine 
and p-lysophosphatidylethanolamine served as acceptors. The rate of 
transfer of saturated fatty acids onto p-lysophosphatidylcholine was de­
creased, however, in ethanol-treated rats. The effect of ethanol on 
acyltransferase activities for saturated and unsaturated fatty acids mea­
sured in vitro correlates favorably with the changes observed in the sat­
urated and unsaturated fatty acid composition of phosphatidylcholine, as
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well as the lack of change of phosphatidylethanolamine, in ethanol-treated 
rats fed corn oil. These observations suggest that the administration of 
ethanol to these rats produced specific changes in the acyltransferases 
involved in phosphatidylcholine metabolism.
Results obtained in the present study also suggest that nutri­
tional factors may influence these acyltransferases. Ethanol had little 
effect on the activities which transfer unsaturated fatty acids onto q- 
lysophosphatidylcholine in rats fed coconut oil, whereas a marked in­
crease in these activities was observed when ethanol was given to rats 
fed corn oil. This lack of response to ethanol in respect to the acyl- 
transferases in rats fed coconut oil is consistent with the observation 
that similar proportions of saturated and unsaturated fatty acids were 
found in controls and ethanol-treated rats fed coconut oil.
Fallon and co-workers (205, 206) have reported that ethanol in­
creased the rate of conversion of phosphatidylethanolamine to phospha­
tidylcholine, based on the incorporation into the latter of radioactivity 
from methionine labeled in the methyl group. Additional studies are re­
quired to evaluate whether the enzyme system catalyzing this transmethyl­
ation reaction demonstrates a fatty acid specificity.
CHAPTER VI
SUMMARY
1. Chronic administration of ethanol to rats produced an in­
crease in hepatic contents of triglyceride, cholesterol, phosphatidyl­
choline and phosphatidylethanolamine, when compared with values obtained 
from controls fed an isocaloric liquid diet. Serum concentrations of 
these lipids were also increased in ethanol-treated rats.
2. Ethanol increased the incorporation of glycerol-C^^ into 
hepatic triglyceride (increased by 56% of control value), phosphatidyl­
choline (35%) and phosphatidylethanolamine (9%) during the first two hours 
after isotope administration.
Measurements of half-time values for hepatic glycerolipids, 
obtained using glycerol-H^, demonstrated that ethanol produced a moderate 
increase in the absolute turnover rate of triglyceride and phosphatidyl­
choline, as well as a small increase in the absolute and fractional turn­
over rates of phosphatidylethanolamine. The fractional turnover rates of 
triglyceride and phosphatidylcholine in ethanol-treated rats were lower, 
however, than in controls.
These observations suggest that the accumulation of trigly­
ceride, phosphatidylcholine and, to a lesser extent, phosphatidylethanol­
amine in the liver of ethanol-treated rats is due primarily to an increase
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in the rates of synthesis of these glycerolipids, rather than an impair­
ment in removal mechanisms.
3. The total proportions of unsaturated fatty acids present in 
hepatic triglyceride, phosphatidylcholine and phosphatidylethanolamine 
were higher in controls fed corn oil as the sole source of dietary tri­
glyceride than in those fed coconut oil. Ethanol increased the total
<
proportion of unsaturated fatty acids in hepatic triglyceride and phos­
phatidylcholine (compared with controls fed corn oil), as well as the 
total proportion of saturated fatty acids in hepatic triglyceride from 
rats fed coconut oil (conpared with controls fed coconut oil). The total 
proportion of saturated fatty acids in phosphatidylcholine was similar 
in ethanol-treated and control rats fed coconut oil. In addition, ethanol 
produced no,statistically significant change in the fatty acid composi­
tion of hepatic phosphatidylethanolamine in rats fed either corn oil or 
coconut oil.
These results are consistent with the conclusion that a sig­
nificant proportion of the triglyceride wrtiich accumulates in the liver 
during prolonged ethanol administration contains fatty acids derived from 
dietary triglyceride.
4. Transferase activity in rat liver microsomes was assayed 
using CoA-derivatives of palmitic, stearic, oleic, linoleic and arachi­
donic acid as fatty acyl donors and a- and p-lysophosphatidylcholine and 
a- and p-lysophosphatidylethanolamine as fatty acyl acceptors. A marked 
increase in rates of transfer of unsaturated fatty acids onto a-lysophos­
phatidyl chol ine and a decrease in the rates of transfer of saturated 
fatty acids onto p-lysophosphatidylcholine were observed in ethanol-
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treated rats fed corn oil. Ethanol failed to produce a similar response 
in rats fed coconut oil, however, suggesting that the fatty acid composi­
tion of dietary triglyceride may modify the ethanol-induced changes in 
these acyltransferases. The rates of transfer of both saturated and un­
saturated fatty acids onto a-lysophosphatidylethanolamine were increased 
slightly in ethanol-treated rats, but little change was evident in the 
values obtained for the transfer of fatty acids onto p-lysophosphatidyl- 
ethanolamine.
The effect of ethanol on acyltransferase activities for sat­
urated and unsaturated fatty acids measured in vitro correlates favorably 
with the changes in the saturated and unsaturated fatty acid composition 
of phosphatidylcholine, as well as the lack of change of phosphatidyl­
ethanolamine, in ethanol-treated rats.
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